BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797-805. [PMID: 17326206 DOI: 10.1002/hep.21563] [Cited by in Crossref: 914] [Cited by in F6Publishing: 796] [Article Influence: 60.9] [Reference Citation Analysis]
Number Citing Articles
1 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa0801209] [Cited by in Crossref: 752] [Cited by in F6Publishing: 270] [Article Influence: 53.7] [Reference Citation Analysis]
2 Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JM. Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy. World J Gastroenterol 2017; 23(37): 6868-6876 [PMID: 29085229 DOI: 10.3748/wjg.v23.i37.6868] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
3 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164-1175. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
4 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa080120910.1053/jhep.2001.22172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wernly B, Lichtenauer M, Franz M, Kabisch B, Muessig J, Masyuk M, Hoppe UC, Kelm M, Jung C. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance. PLoS One 2017;12:e0170987. [PMID: 28151948 DOI: 10.1371/journal.pone.0170987] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
6 Fukazawa K, Nishida S, Pretto EA, Vater Y, Reyes JD. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation: Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. J Hepatobiliary Pancreat Sci 2016;23:406-13. [DOI: 10.1002/jhbp.355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients. Alcohol Clin Exp Res. 2013;37:244-251. [PMID: 23009036 DOI: 10.1111/j.1530-0277.2012.01925.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
8 Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. Am J Gastroenterol 2021;116:1406-13. [PMID: 33811202 DOI: 10.14309/ajg.0000000000001228] [Reference Citation Analysis]
9 Esser H, Resch T, Pamminger M, Mutschlechner B, Troppmair J, Riedmann M, Gassner E, Maglione M, Margreiter C, Boesmueller C, Oberhuber R, Weissenbacher A, Cardini B, Finkenstedt A, Zoller H, Tilg H, Öfner D, Schneeberger S. Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation. Transplantation 2019;103:2506-14. [PMID: 30985737 DOI: 10.1097/TP.0000000000002759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Anastasiou OE, Kälsch J, Hakmouni M, Kucukoglu O, Heider D, Korth J, Manka P, Sowa JP, Bechmann L, Saner FH, Paul A, Gerken G, Baba HA, Canbay A. Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure. Liver Int 2017;37:1032-41. [PMID: 28109050 DOI: 10.1111/liv.13369] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
11 Matanes F, Twal WO, Hammad SM. Sphingolipids as Biomarkers of Disease. In: Stiban J, editor. Bioactive Ceramides in Health and Disease. Cham: Springer International Publishing; 2019. pp. 109-38. [DOI: 10.1007/978-3-030-21162-2_7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
12 Gringeri E, D'amico F, Bassi D, Mescoli C, Bonsignore P, Boetto R, Lodo E, Noaro G, Polacco M, D'amico F, Boccagni P, Zanus G, Brolese A, Cillo U. Liver Transplantation for Massive Hepatomegaly Due to Polycystic Liver Disease: An Extreme Case. Transplantation Proceedings 2012;44:2038-40. [DOI: 10.1016/j.transproceed.2012.06.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Sala A, Lorusso R, Bargagna M, Ruggeri S, Buzzatti N, Scandroglio M, Monaco F, Agricola E, Giacomini A, Carino D, Meneghin R, Schiavi D, Lapenna E, Denti P, Blasio A, Alfieri O, Castiglioni A, De Bonis M. Complicated postoperative course in isolated tricuspid valve surgery: Looking for predictors. J Card Surg 2021;36:3092-9. [PMID: 34131952 DOI: 10.1111/jocs.15739] [Reference Citation Analysis]
14 Li C, Mi K, Wen TF, Yan LN, Li B, Wei YG, Yang JY, Xu MQ, Wang WT. Risk factors and outcomes of massive red blood cell transfusion following living donor liver transplantation. J Dig Dis. 2012;13:161-167. [PMID: 22356311 DOI: 10.1111/j.1751-2980.2011.00570.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57:274-280. [PMID: 22521353 DOI: 10.1016/j.jhep.2012.03.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
16 Wang J, Zhang Z, Yan X, Li M, Xia J, Liu Y, Chen Y, Jia B, Zhu L, Zhu C, Huang R, Wu C. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Digestive and Liver Disease 2019;51:1172-8. [DOI: 10.1016/j.dld.2019.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
17 Roberson JL, Lagasca AM, Kan VL. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015. AIDS Res Hum Retroviruses 2018;34:148-55. [PMID: 28974107 DOI: 10.1089/AID.2017.0092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Kelly SG, Campbell TC, Hillman L, Said A, Lucey MR, Agarwal PD. The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review. Annals of Hepatology 2017;16:395-401. [DOI: 10.5604/01.3001.0009.8594] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
19 Harrington PB, McAlexander WW, Bryant AS, Wallace P, Massey J, Gray S, Kukreja M, Cleveland DC, Kirklin JK, Davies JE. Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation. Ann Thorac Surg 2017;103:541-5. [PMID: 27623271 DOI: 10.1016/j.athoracsur.2016.06.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Gao F, Sun L, Ye X, Liu Y, Liu H, Geng M, Li X, Yang X, Li Y, Wang R. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Eur J Gastroenterol Hepatol. 2017;29:669-678. [PMID: 28195876 DOI: 10.1097/MEG.0000000000000854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Massicotte L, Carrier FM, Karakiewicz P, Hevesi Z, Thibeault L, Nozza A, Bilodeau M, Roy A, Denault AY. Impact of MELD Score-Based Organ Allocation on Mortality, Bleeding, and Transfusion in Liver Transplantation: A Before-and-After Observational Cohort Study. J Cardiothorac Vasc Anesth 2019;33:2719-25. [PMID: 31072701 DOI: 10.1053/j.jvca.2019.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ, Ijzermans JNM. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int 2018;31:165-74. [DOI: 10.1111/tri.13048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
23 Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol 2019;18:30-9. [PMID: 31113606 DOI: 10.5604/01.3001.0012.7859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Alghamdi T, Abdel-Fattah M, Zautner A, Lorf T. Preoperative model for end-stage liver disease score as a predictor for posthemihepatectomy complications. Eur J Gastroenterol Hepatol 2014;26:668-75. [PMID: 24743499 DOI: 10.1097/MEG.0000000000000035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
25 Albarmawi A, Czock D, Gauss A, Ehehalt R, Lorenzo Bermejo J, Burhenne J, Ganten TM, Sauer P, Haefeli WE. CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores. Br J Clin Pharmacol. 2014;77:160-169. [PMID: 23772874 DOI: 10.1111/bcp.12182] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
26 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H, Uemoto S. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle 2018;9:246-54. [PMID: 29453829 DOI: 10.1002/jcsm.12276] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
27 Glavind E, Aagaard NK, Grønbæk H, Møller HJ, Orntoft NW, Vilstrup H, Thomsen KL. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. PLoS One 2016;11:e0158388. [PMID: 27379798 DOI: 10.1371/journal.pone.0158388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
28 Jones BE, Allegretti AS, Pose E, Mara KC, Ufere NN, Avitabile E, Shah VH, Kamath PS, Ginès P, Simonetto DA. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci 2021. [PMID: 33604793 DOI: 10.1007/s10620-021-06864-z] [Reference Citation Analysis]
29 Hu Z, Zhou J, Li Z, Xiang J, Zhang Q, Yan S, Wu J, Zhang M, Wang W, Zheng S. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score. J Hepatobiliary Pancreat Sci 2017;24:206-16. [PMID: 28107613 DOI: 10.1002/jhbp.435] [Reference Citation Analysis]
30 Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB; Canadian Co-infection Cohort Study (CTN 222). A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. PLoS One 2017;12:e0176282. [PMID: 28467457 DOI: 10.1371/journal.pone.0176282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N. Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis: Predictive factors of tolvaptan efficacy for LC. Hepatol Res 2018;48:E311-9. [DOI: 10.1111/hepr.12988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
32 Xu B, Li XL, Ye F, Zhu XD, Shen YH, Huang C, Zhou J, Fan J, Chen YJ, Sun HC. Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure. J Clin Transl Hepatol 2021;9:291-300. [PMID: 34221915 DOI: 10.14218/JCTH.2021.00013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chapman WC, Garcia-Aroz S, Vachharajani N, Fowler K, Saad N, Lin Y, Wellen J, Tan B, Khan AS, Doyle MB. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions. J Am Coll Surg. 2017;224:610-621. [PMID: 28069527 DOI: 10.1016/j.jamcollsurg.2016.12.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
34 Chen F, Shi Y, Liu X, Lei L, Xu J. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol 2019;13:1129-35. [PMID: 31674256 DOI: 10.1080/17474124.2019.1688143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Lewis RS Jr, Vollmer CM Jr. Risk scores and prognostic models in surgery: pancreas resection as a paradigm. Curr Probl Surg 2012;49:731-95. [PMID: 23131540 DOI: 10.1067/j.cpsurg.2012.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-9, 1979.e1-3. [PMID: 21376047 DOI: 10.1053/j.gastro.2011.02.058] [Cited by in Crossref: 265] [Cited by in F6Publishing: 241] [Article Influence: 24.1] [Reference Citation Analysis]
37 Li J, Hu CH, Chen Y, Zhou MM, Gao ZJ, Fu MJ, Wang J, Li JZ, Chen TY, Zhao YR, He YL. Characteristics of Peripheral Lymphocyte Subsets in Patients With Acute-On-Chronic Liver Failure Associated With Hepatitis B. Front Med (Lausanne) 2021;8:689865. [PMID: 34386507 DOI: 10.3389/fmed.2021.689865] [Reference Citation Analysis]
38 Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ. Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis. Korean J Hepatol 2009;15:350. [DOI: 10.3350/kjhep.2009.15.3.350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
39 Tandon M, Singh H, Singla N, Jain P, Pandey CK. Tongue thickness in health vs cirrhosis of the liver: Prospective observational study. World J Gastrointest Pharmacol Ther 2020; 11(3): 59-68 [PMID: 32844044 DOI: 10.4292/wjgpt.v11.i3.59] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V, Wallaert B, Mathurin P, Pruvot FR. Impact of impaired aerobic capacity on liver transplant candidates. Transplantation. 2008;86:1077-1083. [PMID: 18946345 DOI: 10.1097/tp.0b013e318187758b] [Cited by in Crossref: 86] [Cited by in F6Publishing: 18] [Article Influence: 6.1] [Reference Citation Analysis]
41 Schouten J, Francque S, Van Vlierberghe H, Colle I, Nevens F, Delwaide J, Adler M, Starkel P, Ysebaert D, Gadisseur A, De Winter B, Smits J, Rahmel A, Michielsen P. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth: Laboratory-induced differences in MELD score. Clinical Transplantation 2012;26:E62-70. [DOI: 10.1111/j.1399-0012.2011.01538.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
42 Cimen S, Guler S, Ayloo S, Molinari M. Implications of Hyponatremia in Liver Transplantation. J Clin Med 2014;4:66-74. [PMID: 26237018 DOI: 10.3390/jcm4010066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Fuster J. Surgical treatment of hepatocellular carcinoma: should resection be performed according to Barcelona Clinic Liver Cancer classification? Hepat Oncol 2015;2:245-53. [PMID: 30191006 DOI: 10.2217/hep.15.18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, Keough A, Llop E, González A, Seijo S. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412-419.e3. [PMID: 24148622 DOI: 10.1053/j.gastro.2013.10.018] [Cited by in Crossref: 157] [Cited by in F6Publishing: 115] [Article Influence: 17.4] [Reference Citation Analysis]
45 Lüthold SC, Kaseje N, Jannot AS, Mentha G, Majno P, Toso C, Belli DC, McLin VA, Wildhaber BE. Risk factors for early and late biliary complications in pediatric liver transplantation. Pediatr Transplant. 2014;18:822-830. [PMID: 25263826 DOI: 10.1111/petr.12363] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
46 Montano-loza AJ, Hansen BE, Corpechot C, Roccarina D, Thorburn D, Trivedi P, Hirschfield G, Mcdowell P, Poupon R, Dumortier J, Bosch A, Giostria E, Conti F, Parés A, Reig A, Floreani A, Russo FP, Goet JC, Harms MH, van Buuren H, Van den Ende N, Nevens F, Verhelst X, Donato MF, Malinverno F, Ebadi M, Mason AL. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival. Gastroenterology 2019;156:96-107.e1. [DOI: 10.1053/j.gastro.2018.10.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 13.3] [Reference Citation Analysis]
47 Wang R, Qi X, Guo X. Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis. Exp Ther Med 2017;14:5733-42. [PMID: 29285115 DOI: 10.3892/etm.2017.5321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
48 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Findlay JY. Exercise for all? Liver Transpl 2012;18:143-5. [PMID: 22162225 DOI: 10.1002/lt.22482] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Yang JD, Kim WR, Park KW, Chaiteerakij R, Kim B, Sanderson SO, Larson JJ, Pedersen RA, Therneau TM, Gores GJ. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012;56:614-621. [PMID: 22370914 DOI: 10.1002/hep.25680] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
51 Takamoto T, Sugawara Y, Hashimoto T, Makuuchi M. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2016;10:341-57. [PMID: 26558422 DOI: 10.1586/17474124.2016.1116381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
52 Tsiompanidis E, Siakavellas SI, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A, Oikonomou K, Tentolouris N. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity. World J Gastrointest Pathophysiol 2018; 9(1): 28-36 [PMID: 29487764 DOI: 10.4291/wjgp.v9.i1.28] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
53 Egbe A, Miranda WR, Connolly HM, Khan AR, Al-otaibi M, Venkatesh SK, Simonetto D, Kamath P, Warnes C. Temporal changes in liver stiffness after Fontan operation: Results of serial magnetic resonance elastography. International Journal of Cardiology 2018;258:299-304. [DOI: 10.1016/j.ijcard.2018.01.108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
54 Hu N, Xie XC, Liu LL, Lai WD. Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Medicine (Baltimore) 2021;100:e26066. [PMID: 34032735 DOI: 10.1097/MD.0000000000026066] [Reference Citation Analysis]
55 Molinari M, Renfrew PD, Petrie NM, De Coutere S, Abdolell M. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas. Transpl Int 2011;24:292-9. [PMID: 21143650 DOI: 10.1111/j.1432-2277.2010.01200.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Jacquelinet C, Audry B, Pessione F, Antoine C, Loty B, Calmus Y. Règles d’attribution des greffons hépatiques. La Presse Médicale 2008;37:1782-6. [DOI: 10.1016/j.lpm.2008.01.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
57 Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 2020;98:836-46. [PMID: 33027788 DOI: 10.1159/000502482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Hemprich U, Papadakos PJ, Lachmann B. Respiratory failure and hypoxemia in the cirrhotic patient including hepatopulmonary syndrome. Curr Opin Anaesthesiol. 2010;23:133-138. [PMID: 20019600 DOI: 10.1097/aco.0b013e328335f024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
59 Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E, Caraceni P, Domenicali M, Felline P, Zoli M. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol. 2008;48:415-421. [PMID: 18194821 DOI: 10.1016/j.jhep.2007.11.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
60 Oliveira MS, Silva RPM, Valle SDCND, Souza RM, Figueiredo EN, Taminato M, Fram DS. Hepatitis B and Delta: clinical aspects of patients in the Brazilian Western Amazonia. Rev Bras Enferm 2019;72:1265-70. [PMID: 31531650 DOI: 10.1590/0034-7167-2018-0100] [Reference Citation Analysis]
61 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr 2020;39:1885-92. [PMID: 31481263 DOI: 10.1016/j.clnu.2019.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
62 Colmenero J, Castro-Narro G, Navasa M. [The value of MELD in the allocation of priority for liver transplantation candidates]. Gastroenterol Hepatol 2010;33:330-6. [PMID: 19631411 DOI: 10.1016/j.gastrohep.2009.04.007] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
63 Brigo S, Mancuso E, Pellicano R. Dentistry and oral and maxillofacial surgery in the patient with liver disease: key messages for clinical practice. Minerva Stomatol 2019;68:192-9. [PMID: 31140770 DOI: 10.23736/S0026-4970.19.04216-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462-470. [PMID: 21109324 DOI: 10.1016/j.jhep.2010.07.015] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
65 Mao B, Sun L, Zhang J, Zhou M, Zhang F. Perioperative factors associated with short- and long-term outcomes after tricuspid valve replacement. Interact CardioVasc Thorac Surg 2016;23:845-50. [DOI: 10.1093/icvts/ivw244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
66 Saad WE, Wagner C(, Al-osaimi A, Bliebel W, Lippert A, Davies MG, Sabri SS, Turba UC, Matsumoto AH, Angle J(, Caldwell S. The Effect of Balloon-Occluded Transvenous Obliteration of Gastric Varices and Gastrorenal Shunts on the Hepatic Synthetic Function: A Comparison Between Child-Pugh and Model for End-Stage Liver Disease Scores. Vasc Endovascular Surg 2013;47:281-7. [DOI: 10.1177/1538574413485646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
67 Marlar RA. Determining the model for end-stage liver disease with better accuracy: neutralizing the international normalized ratio pitfalls. Hepatology 2007;46:295-6. [PMID: 17661420 DOI: 10.1002/hep.21833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
68 Hafeez M, Nadeem M, Ahmed M, Faheem-Ur-Rehman. Hepatocellular Carcinoma (HCC), Where do we stand? Current situation. Pak J Med Sci 2020;36:344-8. [PMID: 32292431 DOI: 10.12669/pjms.36.3.1594] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Asrani SK, Kim WR, Edwards EB, Larson JJ, Thabut G, Kremers WK, Therneau TM, Heimbach J. Impact of the center on graft failure after liver transplantation. Liver Transpl 2013;19:957-64. [PMID: 23784730 DOI: 10.1002/lt.23685] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
70 Ye Q, Cai JJ, Yan JQ, Lv R. Role of L3-PMI in prognostic evaluation of patients with acute-on-chronic liver failure related to hepatitis B cirrhosis. Shijie Huaren Xiaohua Zazhi 2021; 29(20): 1167-1173 [DOI: 10.11569/wcjd.v29.i20.1167] [Reference Citation Analysis]
71 Wang J, Huang R, Yan X, Li M, Chen Y, Xia J, Liu Y, Jia B, Zhu L, Zhang Z, Zhu C, Wu C. Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus-related diseases. Dig Liver Dis 2020;52:440-6. [PMID: 32008975 DOI: 10.1016/j.dld.2019.12.144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Kahraman AS, Kahraman B, Ozdemir ZM, Gormeli CA, Ozdemir F, Dogan M. Diffusion-weighted imaging (DWI) of the liver in assessing chronic liver disease: effects of the presence and the degree of ascites on ADC values. Abdom Radiol (NY). 2016;41:56-62. [PMID: 26830612 DOI: 10.1007/s00261-015-0613-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Maesaka K, Sakamori R, Yamada R, Tahata Y, Oshita M, Hagiwara H, Sakakibara M, Tamura S, Hiramatsu N, Inada M, Iio S, Ito T, Yakushijin T, Doi Y, Kodama T, Hikita H, Tatsumi T, Takehara T. Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment. Hepatol Res 2021;51:517-27. [PMID: 33507588 DOI: 10.1111/hepr.13623] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
74 Doyle MB, Subramanian V, Vachharajani N, Maynard E, Shenoy S, Wellen JR, Lin Y, Chapman WC. Results of Simultaneous Liver and Kidney Transplantation: A Single-Center Review. J Am Coll Surg. 2016;223:193-201. [PMID: 27103549 DOI: 10.1016/j.jamcollsurg.2016.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
75 Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG. Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:248-253. [PMID: 21669566 DOI: 10.1016/s1499-3872(11)60041-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Mardini H, Smith FE, Record CO, Blamire AM. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol. 2011;54:1154-1160. [PMID: 21145802 DOI: 10.1016/j.jhep.2010.09.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
77 Dyla A, Mielnicki W, Bartczak J, Zawada T, Garba P. Effectiveness and Safety Assessment of Citrate Anticoagulation During Albumin Dialysis in Comparison to Other Methods of Anticoagulation. Artif Organs 2017;41:818-26. [PMID: 28337775 DOI: 10.1111/aor.12876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
78 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
79 Loforte A, Fiorentino M, Gliozzi G, Mariani C, Folesani G, Suarez SM, Russo A, Masetti M, Potena L, Pacini D. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes. Transplant Proc 2019;51:2962-6. [PMID: 31607616 DOI: 10.1016/j.transproceed.2019.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
80 Yang J, Yan B, Yang L, Li H, Fan Y, Zhu F, Zheng J, Ma X. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study. BMC Gastroenterol 2018;18:161. [PMID: 30384828 DOI: 10.1186/s12876-018-0893-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
81 Urbani L, Mazzoni A, Bindi L, Biancofiore G, Bisã  M, Meacci L, Esposito M, Mozzo R, Colombatto P, Bianco I, Grazzini T, Coletti L, De Simone P, Catalano G, Montin U, Tincani G, Balzano E, Petruccelli S, Carrai P, Tascini C, Menichetti F, Scatena F, Filipponi F. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation. Clinical Transplantation 2009;23:853-60. [DOI: 10.1111/j.1399-0012.2009.00957.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Tanaka H, Imai H, Higashi T, Murase K, Matsuhashi N, Yoshida K. Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report. Int J Surg Case Rep 2021;81:105715. [PMID: 33689973 DOI: 10.1016/j.ijscr.2021.105715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Potts JR, Verma S. Alcoholic hepatitis: diagnosis and management in 2012. Expert Rev Gastroenterol Hepatol. 2012;6:695-710. [PMID: 23237255 DOI: 10.1586/egh.12.57] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
84 Calmus Y, Jacquelinet C. Nouvelles règles d’attribution des greffons hépatiques. Gastroentérologie Clinique et Biologique 2008;32:585-8. [DOI: 10.1016/j.gcb.2008.01.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
85 Lim N, Lidofsky SD. Impact of physician specialty on quality care for patients hospitalized with decompensated cirrhosis. PLoS One. 2015;10:e0123490. [PMID: 25837700 DOI: 10.1371/journal.pone.0123490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
86 Piscaglia F, Cucchetti A, Bolondi L. “Survival benefit”: The final destination, with still a long way to go. Digestive and Liver Disease 2010;42:608-10. [DOI: 10.1016/j.dld.2010.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
87 Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386:1576-1587. [PMID: 26423181 DOI: 10.1016/s0140-6736(15)00309-8] [Cited by in Crossref: 153] [Cited by in F6Publishing: 59] [Article Influence: 21.9] [Reference Citation Analysis]
88 Collins KM, Chapman WC. High-risk liver transplant candidates: An ethical proposal on where to draw the line. Liver Transpl 2015;21:567-9. [DOI: 10.1002/lt.24127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 Ehsani MJ, Mahdavi Jafari J, Aliasl J, Kamalinejad M, Gachkar L, Choopani R. Effect of diet based on the principles of Iranian traditional medicine on cirrhosis (a clinical trial). Complement Ther Med 2016;29:35-41. [PMID: 27912954 DOI: 10.1016/j.ctim.2016.09.006] [Reference Citation Analysis]
90 Fujiyama S, Saitoh S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol 2017;17:112. [PMID: 29070023 DOI: 10.1186/s12876-017-0668-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
91 Khalifa A, Rockey DC. Lower Gastrointestinal Bleeding in Patients With Cirrhosis-Etiology and Outcomes. Am J Med Sci 2020;359:206-11. [PMID: 32087941 DOI: 10.1016/j.amjms.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Unger LW, Herac M, Staufer K, Salat A, Silberhumer G, Hofmann M, Trauner M, Rasoul-rockenschaub S, Soliman T, Reiberger T, Berlakovich GA. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case–control study. European Journal of Gastroenterology & Hepatology 2017;29:309-16. [DOI: 10.1097/meg.0000000000000794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
93 Kartoun U. Toward an accelerated adoption of data-driven findings in medicine: Research, skepticism, and the need to speed up public visibility of data-driven findings. Med Health Care and Philos 2019;22:153-7. [DOI: 10.1007/s11019-018-9845-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
94 Hoffmann K, Hinz U, Hillebrand N, Ganten T, Gotthardt D, Longerich T, Schirmacher P, Schemmer P. The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases. Langenbecks Arch Surg. 2014;399:1001-1009. [PMID: 25106131 DOI: 10.1007/s00423-014-1237-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
95 Chen X, Zou H, Xiong L, Huang SF, Miao XY, Wen Y. Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients. World J Surg Oncol 2017;15:216. [PMID: 29202837 DOI: 10.1186/s12957-017-1281-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
96 Belarmino G, Torrinhas RS, Magalhães NV, Heymsfield SB, Waitzberg DL. New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis. Nutrition 2021;84:111083. [PMID: 33418229 DOI: 10.1016/j.nut.2020.111083] [Reference Citation Analysis]
97 Than NN, Tomlinson CL, Haldar D, King AL, Moore D, Newsome PN. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev. 2016;5:100. [PMID: 27301957 DOI: 10.1186/s13643-016-0277-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
98 Kim SH, Oh S, Nham E, Ko JH, Huh K, Cho SY, Kang CI, Chung DR, Choi GS, Kim JM, Joh JW, Peck KR. Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay. Int J Infect Dis 2021;113:359-66. [PMID: 34718154 DOI: 10.1016/j.ijid.2021.10.043] [Reference Citation Analysis]
99 Lalazar G, Adar T, Ilan Y. Point-of-care continuous 13C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial. World J Gastroenterol 2009; 15(8): 966-972 [PMID: 19248196 DOI: 10.3748/wjg.15.966] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
100 Zhao W, Xue N, Cui P, Liu L, Wang Y, Zhang X, Tang Y, Du H, Nan Y. Plasma YAP1 predicts esophageal varices and the risk of variceal bleeding in liver cirrhosis. Biomark Med 2021;15:1411-22. [PMID: 34533050 DOI: 10.2217/bmm-2020-0573] [Reference Citation Analysis]
101 Chiang HC, Chien YC, Lin PY, Lee HL, Chen YL. Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings. PLoS One 2018;13:e0206438. [PMID: 30458009 DOI: 10.1371/journal.pone.0206438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Kemmer N, Safdar K, Kaiser T, Zacharias V, Neff GW. Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation. 2008;85:166-170. [PMID: 18212619 DOI: 10.1097/tp.0b013e31816223f8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
103 Amouzandeh M, Nowak G, Januszkiewicz A, Wernerman J, Rooyackers O, Norberg Å. Albumin mass balance and kinetics in liver transplantation. Crit Care 2018;22:152. [PMID: 29880012 DOI: 10.1186/s13054-018-2053-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
104 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
105 Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, Chartier M, DiMartini A, Morgan T, Bataller R, Kraemer KL. Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis. Hepatology 2020;71:2080-92. [PMID: 31758811 DOI: 10.1002/hep.31042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
106 Navuluri R, Patel J, Kang L. Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding. Semin Intervent Radiol. 2012;29:169-177. [PMID: 23997408 DOI: 10.1055/s-0032-1326925] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
107 Fuhrman DY, Kellum JA, Joyce EL, Miyashita Y, Mazariegos GV, Ganoza A, Squires JE. The use of urinary biomarkers to predict acute kidney injury in children after liver transplant. Pediatr Transplant 2020;24:e13608. [PMID: 31652022 DOI: 10.1111/petr.13608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
108 Biancofiore G, Bindi L, Miccoli M, Metelli MR, Panicucci E, Baggiani A, Filipponi F. Balance of pro- and anti-inflammatory cytokines in cirrhotic patients undergoing liver transplantation. Transplant Immunology 2013;28:193-7. [DOI: 10.1016/j.trim.2013.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
109 Sigal SH, Amin A, Chiodo JA 3rd, Sanyal A. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry. Can J Gastroenterol Hepatol 2018;2018:1579508. [PMID: 30363747 DOI: 10.1155/2018/1579508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
110 Li J, Liang X, You S, Feng T, Zhou X, Zhu B, Luo J, Xin J, Jiang J, Shi D, Lu Y, Ren K, Wu T, Yang L, Li J, Li T, Cai Q, Sun S, Guo B, Zhou X, Chen J, He L, Li P, Yang H, Hu W, An Z, Jin X, Tian J, Wang B, Chen X, Xin S, Li J; Chinese Group on the Study of Severe Hepatitis B (COSSH). Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol 2021:S0168-8278(21)00399-8. [PMID: 34090929 DOI: 10.1016/j.jhep.2021.05.026] [Reference Citation Analysis]
111 Moreau R, Durand F. Renal insufficiency: Management prior to transplantation. Liver Transpl 2010;16:S72-6. [DOI: 10.1002/lt.22143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
112 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Hammad A, Okajima H, Uemoto S. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation. Transplantation 2016;100:2416-23. [DOI: 10.1097/tp.0000000000001413] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
113 El-Saadany S, El-Demerdash T, Helmy A, Mayah WW, El-Sayed Hussein B, Hassanien M, Elmashad N, Fouad MA, Basha EA. Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas. Asian Pac J Cancer Prev 2018;19:811-7. [PMID: 29582639 DOI: 10.22034/APJCP.2018.19.3.811] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
114 Kaiser T, Kinny-Köster B, Bartels M, Berg T, Scholz M, Engelmann C, Seehofer D, Becker S, Ceglarek U, Thiery J. Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality. BMC Gastroenterol 2017;17:57. [PMID: 28427335 DOI: 10.1186/s12876-017-0614-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
115 Carson SS, Kahn JM, Hough CL, Seeley EJ, White DB, Douglas IS, Cox CE, Caldwell E, Bangdiwala SI, Garrett JM, Rubenfeld GD; ProVent Investigators. A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. Crit Care Med 2012;40:1171-6. [PMID: 22080643 DOI: 10.1097/CCM.0b013e3182387d43] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
116 Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care. 2011;17:165-169. [PMID: 21326095 DOI: 10.1097/mcc.0b013e328344b42d] [Cited by in Crossref: 115] [Cited by in F6Publishing: 49] [Article Influence: 10.5] [Reference Citation Analysis]
117 Xing XY, Liu M, Zheng SJ, Zhang Y, Wu JS, Yu H, Li CY, Bai L, Liu S, Duan ZP. Significance of serum apolipoprotein levels in assessing the degree of liver injury in patients with HBV-related chronic liver disease. Shijie Huaren Xiaohua Zazhi 2011; 19(3): 295-300 [DOI: 10.11569/wcjd.v19.i3.295] [Reference Citation Analysis]
118 Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med 2021;13:45-57. [PMID: 34079394 DOI: 10.2147/HMER.S278032] [Reference Citation Analysis]
119 Heimbach JK. United States liver allocation. Current Opinion in Organ Transplantation 2020;25:104-9. [DOI: 10.1097/mot.0000000000000740] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Vitalis Z, Altorjay I, Tornai I, Palatka K, Kacska S, Palyu E, Tornai D, Udvardy M, Harsfalvi J, Dinya T. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis. Hum Immunol. 2011;72:348-354. [PMID: 21262313 DOI: 10.1016/j.humimm.2011.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
121 Li C, Mi K, Wen Tf, Yan Ln, Li B, Yang Jy, Xu Mq, Wang WT, Wei Yg. A learning curve for living donor liver transplantation. Dig Liver Dis. 2012;44:597-602. [PMID: 22387283 DOI: 10.1016/j.dld.2012.01.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
122 Shili-Masmoudi S, Wong GL, Hiriart JB, Liu K, Chermak F, Shu SS, Foucher J, Tse YK, Bernard PH, Yip TC, Merrouche W, Chan HL, Wong VW, de Lédinghen V. Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease. Liver Int 2020;40:581-9. [PMID: 31749300 DOI: 10.1111/liv.14301] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
123 Nicoll A. Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol. 2012;27:1569-1575. [PMID: 22694313 DOI: 10.1111/j.1440-1746.2012.07205.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
124 Srinivas TR, Stephany BR, Budev M, Mason DP, Starling RC, Miller C, Goldfarb DA, Flechner SM, Poggio ED, Schold JD. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol 2010;5:1881-6. [PMID: 20813856 DOI: 10.2215/CJN.02950410] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
125 Fayad L, Narciso-schiavon JL, Lazzarotto C, Ronsoni MF, Wildner LM, Bazzo ML, Schiavon LDL, Dantas-corrêa EB. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. Annals of Hepatology 2015;14:83-92. [DOI: 10.1016/s1665-2681(19)30804-x] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
126 Laube R, Wang H, Park L, Heyman JK, Vidot H, Majumdar A, Strasser SI, McCaughan GW, Liu K. Frailty in advanced liver disease. Liver Int 2018;38:2117-28. [PMID: 29935102 DOI: 10.1111/liv.13917] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
127 Ding Y, Rao SX, Chen C, Li R, Zeng MS. Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol. 2015;25:1392-1398. [PMID: 25523455 DOI: 10.1007/s00330-014-3542-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
128 Zhang YF, Ji H, Lu HW, Lu L, Wang L, Wang JL, Li YM. Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension. World J Gastroenterol 2018; 24(39): 4499-4509 [PMID: 30356927 DOI: 10.3748/wjg.v24.i39.4499] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
129 Deng Y, Lin L, Hou L, Fan X, Zhao T, Mao L, Wang X, Wang B, Ma Y, Sun C. A self-reported Frailty Index predicts long-term mortality in hospitalized patients with cirrhosis. Ann Transl Med 2020;8:1217. [PMID: 33178749 DOI: 10.21037/atm-20-943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Thandassery RB, Montano-Loza AJ. Role of Nutrition and Muscle in Cirrhosis. Curr Treat Options Gastroenterol. 2016;14:257-273. [PMID: 27023701 DOI: 10.1007/s11938-016-0093-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
131 Flamm SL, Mullen KD, Heimanson Z, Sanyal AJ. Rifaximin has the potential to prevent complications of cirrhosis. Therap Adv Gastroenterol. 2018;11:1756284818800307. [PMID: 30283499 DOI: 10.1177/1756284818800307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
132 Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;28:606-613. [PMID: 18433390 DOI: 10.1111/j.1478-3231.2008.01727.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
133 Lee SA, Hyun J, Yoon YI, Park SY, Lee JS, Kim DH, Song GW, Kim KH, Moon DB, Song JG, Hwang GS, Lee SG, Song JM. Clinical impact of mild to moderate pulmonary hypertension in living-donor liver transplantation. Transpl Int 2021;34:1150-60. [PMID: 33811394 DOI: 10.1111/tri.13875] [Reference Citation Analysis]
134 Kassela K, Karakasiliotis I, Charpantidis S, Koskinas J, Mylopoulou T, Mimidis K, Sarrazin C, Grammatikos G, Mavromara P. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis. J Gen Virol 2017;98:1713-9. [PMID: 28708052 DOI: 10.1099/jgv.0.000851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
135 Feng J, Qu Z, Wu B, Sun D, Jiang Y. The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinoma. Annals of Hepatology 2019;18:701-7. [DOI: 10.1016/j.aohep.2019.04.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
136 Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis. Journal of Hepatology 2013;58:956-61. [DOI: 10.1016/j.jhep.2013.01.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 8.2] [Reference Citation Analysis]
137 Araujo RLC, de Castro LA, Fellipe FEC, Burgardt D, Wohnrath DR. Robotic left lateral sectionectomy as stepwise approach for cirrhotic liver. J Robot Surg 2018;12:549-52. [PMID: 28733780 DOI: 10.1007/s11701-017-0730-0] [Reference Citation Analysis]
138 Biancofiore G, Bindi ML, Miccoli M, Cerutti E, Lavezzo B, Pucci L, Bisà M, Esposito M, Meacci L, Mozzo R, Stratta C, Penno G, Baggiani A, Filipponi F. Intravenous fenoldopam for early acute kidney injury after liver transplantation. J Anesth 2015;29:426-32. [PMID: 25433498 DOI: 10.1007/s00540-014-1951-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
139 Schuetz C, Dong N, Smoot E, Elias N, Schoenfeld DA, Markmann JF, Yeh H. HCC patients suffer less from geographic differences in organ availability. Am J Transplant. 2013;13:2989-2995. [PMID: 24011291 DOI: 10.1111/ajt.12441] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
140 Beste LA, Ioannou GN, Yang Y, Chang MF, Ross D, Dominitz JA. Improved surveillance for hepatocellular carcinoma with a primary care-oriented clinical reminder. Clin Gastroenterol Hepatol 2015;13:172-9. [PMID: 24813175 DOI: 10.1016/j.cgh.2014.04.033] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
141 Xiol X, Gines P, Castells L, Twose J, Ribalta A, Fuentes-Arderiu X, Rodriguez S, Castellote J, Navasa M, Deulofeu R. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl. 2009;15:300-305. [PMID: 19242993 DOI: 10.1002/lt.21688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
142 Guo YM, Li FY, Gong M, Zhang L, Wang JB, Xiao XH, Li J, Zhao YL, Wang LF, Zhang XF. Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial. Chin J Integr Med 2016;22:573-80. [PMID: 27220737 DOI: 10.1007/s11655-016-2582-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
143 Anastasiou OE, Dogan-Cavus B, Kucukoglu O, Baba H, Kahraman A, Gerken G, Schramm C, Canbay A. Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure. Digestion 2018;98:104-11. [PMID: 29698940 DOI: 10.1159/000487940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
144 Warnick P, Mai I, Klein F, Andreou A, Bahra M, Neuhaus P, Glanemann M. Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience. Pancreatology 2011;11:24-9. [PMID: 21336005 DOI: 10.1159/000323961] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
145 Li YH, Xu Y, Wu HM, Yang J, Yang LH, Yue-Meng W. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study. Stem Cell Rev Rep. 2016;12:645-653. [PMID: 27687792 DOI: 10.1007/s12015-016-9683-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
146 Elsayed FG, Sholkamy AA, Elshazli M, Elshafie M, Naguib M. Comparison of different scoring systems in predicting short-term mortality after liver transplantation. Transplant Proc. 2015;47:1207-1210. [PMID: 26036555 DOI: 10.1016/j.transproceed.2014.11.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
147 Johnson KB, Campbell EJ, Chi H, Zheng H, King LY, Wu Y, Delemos A, Hurairah A, Corey K, Richter JM. Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohort. Dig Dis Sci. 2014;59:174-182. [PMID: 23990035 DOI: 10.1007/s10620-013-2832-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
148 Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatol Res. 2015;Epub ahead of print. [PMID: 25847196 DOI: 10.1111/hepr.12520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
149 Montano-Loza AJ, Tandon P, Kneteman N, Bailey R, Bain VG. Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival. Aliment Pharmacol Ther. 2009;30:1060-1069. [PMID: 19723029 DOI: 10.1111/j.1365-2036.2009.04134.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
150 Chen R, Wang X, Dong J, Lin Z, Wu J, Cai Y, Shi K. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2017;468:195-200. [DOI: 10.1016/j.cca.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
151 Soleimanpour H, Safari S, Rahmani F, Ameli H, Alavian SM. The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article. Anesth Pain Med 2015;5:e23409. [PMID: 25789242 DOI: 10.5812/aapm.23409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
152 Campos-Varela I, Castells L. [Prognostic scores of cirrhosis]. Gastroenterol Hepatol 2008;31:439-46. [PMID: 18783690 DOI: 10.1157/13125591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Zhu WS, Shi SY, Yang ZH, Song C, Shen J. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. World J Gastroenterol 2020; 26(11): 1208-1220 [PMID: 32231424 DOI: 10.3748/wjg.v26.i11.1208] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
154 Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis: Diagnostic criteria for acute-onset AIH. Liver International 2011;31:1013-20. [DOI: 10.1111/j.1478-3231.2011.02524.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
155 Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z. Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: The role of laboratory factors. J Magn Reson Imaging 2011;34:301-9. [DOI: 10.1002/jmri.22635] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
156 Donati G, Angeletti A, Gasperoni L, Piscaglia F, Croci Chiocchini AL, Scrivo A, Natali T, Ullo I, Guglielmo C, Simoni P, Mancini R, Bolondi L, La Manna G. Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study). J Nephrol 2021;34:77-88. [PMID: 32710265 DOI: 10.1007/s40620-020-00799-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Alonso IJ, Maestro OC, Gómez NF, Mateos RS, Quinto AM, Molero FC, Municio AM, Pulido JC, Segurola CL, Romero CJ. Mind the model for end-stage liver disease: model for end-stage liver disease score as an indicator of hemoderivate transfusion and survival in liver transplantation. Transplant Proc 2015;47:97-9. [PMID: 25645781 DOI: 10.1016/j.transproceed.2014.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
158 Li C, Wen TF, Mi K, Wang C, Yan LN, Li B. Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol 2012; 18(16): 1975-1980 [PMID: 22563180 DOI: 10.3748/wjg.v18.i16.1975] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
159 Asrani SK, Kim WR, Kamath PS. Race and receipt of liver transplantation: location matters. Liver Transpl 2010;16:1009-12. [PMID: 20818737 DOI: 10.1002/lt.22123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
160 Merlo CA, Weiss ES, Orens JB, Borja MC, Diener-West M, Conte JV, Shah AS. Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant. 2009;28:769-775. [PMID: 19632571 DOI: 10.1016/j.healun.2009.04.024] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 7.2] [Reference Citation Analysis]
161 Swanson A, Geller J, DeMartini K, Fernandez A, Fehon D. Active Coping and Perceived Social Support Mediate the Relationship Between Physical Health and Resilience in Liver Transplant Candidates. J Clin Psychol Med Settings 2018;25:485-96. [PMID: 29546621 DOI: 10.1007/s10880-018-9559-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
162 Frankova S, Lunova M, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Urbanek P, Spicak J, Jirsa M, Sperl J. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLoS One 2021;16:e0244934. [PMID: 33411729 DOI: 10.1371/journal.pone.0244934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol. 2012;28:230-238. [PMID: 22450898 DOI: 10.1097/mog.0b013e3283527f16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
164 Ohashi N, Tsuji N, Naito Y, Iwakura T, Isobe S, Ono M, Fujikura T, Tsuji T, Sakao Y, Yasuda H, Kawamura K, Sakaguchi T, Kato A, Fujigaki Y. Relationship between urinary fractional excretion of sodium and life prognosis in liver cirrhosis patients. Hepatol Res 2013;43:1156-62. [PMID: 23387436 DOI: 10.1111/hepr.12068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
165 Fernandez-Somoza JM, Ginarte M, Otero E, Tomé S, Soutullo C, Martínez-Ulloa A, Gonzalez-Quintela A. Clinical and capillaroscopic findings in patients with liver disease and proximal apparent leukonychia (Terry nails and its variants). Medicine (Baltimore) 2021;100:e26207. [PMID: 34087892 DOI: 10.1097/MD.0000000000026207] [Reference Citation Analysis]
166 Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009;137:1680-1686. [PMID: 19632234 DOI: 10.53/j.gastro.2009.07.047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Barakat M, Khalil M. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome. Arab Journal of Gastroenterology 2011;12:131-5. [DOI: 10.1016/j.ajg.2011.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
168 Czaja AJ. Safety issues in the management of autoimmune hepatitis. Expert Opin Drug Saf. 2008;7:319-333. [PMID: 18462189 DOI: 10.1517/14740338.7.3.319] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
169 Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Am J Gastroenterol. 2016;111:958-965. [PMID: 27045922 DOI: 10.1038/ajg.2016.114] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
170 Lau T, Ahmad J. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013;5:1-10. [PMID: 24696621 DOI: 10.2147/hmer.s9049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
171 Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis. Dig Dis Sci 2009;54:654-60. [DOI: 10.1007/s10620-008-0367-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
172 Sheen SS, Park RW, Yoon D, Shin GT, Kim H, Park IW. The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. J Clin Pharm Ther 2015;40:48-54. [PMID: 25328056 DOI: 10.1111/jcpt.12224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
173 Crawford DH, Stuart K. Adding serum sodium to model for end-stage liver disease: identifying those most at risk. J Gastroenterol Hepatol 2009;24:1804-6. [PMID: 20002937 DOI: 10.1111/j.1440-1746.2009.06028.x] [Reference Citation Analysis]
174 Bruno RR, Wernly B, Hornemann J, Flaatten H, FjØlner J, Artigas A, Bollen Pinto B, Schefold JC, Wolff G, Baldia PH, Binneboessel S, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Elhadi M, Joannidis M, Oeyen S, Kondili E, Wollborn J, Marsh B, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Jung C; COVIP study group. Early evaluation of organ failure using MELD-XI in critically ill elderly COVID-19 patients. Clin Hemorheol Microcirc 2021;79:109-20. [PMID: 34487039 DOI: 10.3233/CH-219202] [Reference Citation Analysis]
175 Considine A, Tredger JM, Heneghan M, Agarwal K, Samyn M, Heaton ND, O'grady JG, Aluvihare VR. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts: CLINICAL USE OF MODIFIED-RELEASE TACROLIMUS. Liver Transpl 2015;21:29-37. [DOI: 10.1002/lt.24022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
176 Rassam F, Olthof PB, Richardson H, van Gulik TM, Bennink RJ. Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function. Nucl Med Commun 2019;40:297-307. [PMID: 30601245 DOI: 10.1097/MNM.0000000000000973] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
177 Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Cichoz-Lach H, Madro A, Szczerbinski M. Angiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome. Mediators Inflamm. 2014;2014:673032. [PMID: 24959006 DOI: 10.1155/2014/673032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
178 Xu L, Ying S, Hu J, Wang Y, Yang M, Ge T, Huang C, Xu Q, Zhu H, Chen Z, Ma W. Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models. Respir Res 2018;19:242. [PMID: 30514312 DOI: 10.1186/s12931-018-0934-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
179 Cavallazzi R, Awe OO, Vasu TS, Hirani A, Vaid U, Leiby BE, Kraft WK, Kane GC. Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis. J Crit Care. 2012;27:424.e1-424.e6. [PMID: 22227088 DOI: 10.1016/j.jcrc.2011.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
180 Cronin DC, Millis JM. Living donor liver transplantation: The ethics and the practice. Hepatology. 2008;47:11-13. [PMID: 18161704 DOI: 10.1002/hep.22150] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
181 Kim J, Ko ME, Nelson RA, Arrington A, Luu C, Falor AE, Nissen NN, Colquhoun S, Hurria A, Singh G. Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer. J Am Coll Surg. 2014;218:431-438. [PMID: 24559955 DOI: 10.1016/j.jamcollsurg.2013.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
182 Liu Z, Wang W, Zhuang L, Liu J, Que S, Zhu D, Dong L, Yu J, Zhou L, Zheng S. Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation. Hepatobiliary Surg Nutr 2020;9:739-58. [PMID: 33299829 DOI: 10.21037/hbsn.2019.12.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065-2076. [PMID: 20949552 DOI: 10.1002/hep.23937] [Cited by in Crossref: 440] [Cited by in F6Publishing: 356] [Article Influence: 36.7] [Reference Citation Analysis]
184 Langholm LL, Manon-Jensen T, Karsdal MA, Bendtsen F, Leeming DJ, Møller S. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis. Eur J Gastroenterol Hepatol 2019;31:1040-8. [PMID: 30768435 DOI: 10.1097/MEG.0000000000001380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Wu Y, Jiang X, Wang S, Jiang W, Li P, Ohno-Machado L. Grid multi-category response logistic models. BMC Med Inform Decis Mak 2015;15:10. [PMID: 25886151 DOI: 10.1186/s12911-015-0133-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
186 Umbro I, Tinti F, Mordenti M, Rossi M, Ianni S, Pugliese F, Ruberto F, Ginanni Corradini S, Nofroni I, Poli L. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation. Transplant Proc. 2011;43:1139-1141. [PMID: 21620072 DOI: 10.1016/j.transproceed.2011.02.045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
187 Zeng Y, Li Y, Xu Z, Gan W, Lu L, Huang X, Lin C. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure. J Med Virol. 2019;91:1510-1518. [PMID: 30905084 DOI: 10.1002/jmv.25466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
188 Dutkowski P, Linecker M, Deoliveira ML, Müllhaupt B, Clavien P. Challenges to Liver Transplantation and Strategies to Improve Outcomes. Gastroenterology 2015;148:307-23. [DOI: 10.1053/j.gastro.2014.08.045] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
189 Feng AC, Chen TW, Fan HL, Yu JC, Hsieh CB. The Correlation of Hepatic and Systemic Hemodynamics During Liver Transplantation: Quantification of Hepatic Resistance as an Actual Value. Medicine (Baltimore) 2015;94:e1815. [PMID: 26512581 DOI: 10.1097/MD.0000000000001815] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
190 Dong MH, Saab S. Complications of cirrhosis. Dis Mon 2008;54:445-56. [PMID: 18570914 DOI: 10.1016/j.disamonth.2008.03.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
191 Al-ebbini L, Oztekin A, Chen Y. FLAS: Fuzzy lung allocation system for US-based transplantations. European Journal of Operational Research 2016;248:1051-65. [DOI: 10.1016/j.ejor.2015.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
192 Wernly B, Lichtenauer M, Vellinga N, Boerma C, Ince C, Kelm M, Jung C. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients. Eur J Intern Med 2018;51:80-4. [PMID: 29572092 DOI: 10.1016/j.ejim.2018.01.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
193 Ceglarek U, Kresse K, Becker S, Fiedler GM, Thiery J, Quante M, Wieland R, Bartels M, Aust G. Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation. Metabolomics 2016;12:182. [PMID: 27840599 DOI: 10.1007/s11306-016-1129-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
194 Meister P, Dechêne A, Büchter M, Kälsch J, Gerken G, Canbay A, Jochum C. Spleen Stiffness Differentiates Between Acute and Chronic Liver Damage and Predicts Hepatic Decompensation. J Clin Gastroenterol 2019;53:457-63. [PMID: 29738353 DOI: 10.1097/MCG.0000000000001044] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
195 Abdel-Aal AK, Dawoud N, Moustafa AS, Hamed MF, Saddekni S. Percutaneous Transhepatic Embolization of Bleeding Rectal Varices Using A New Embolic And Sclerotic Mixture Augmented By Amplatzer Vascular Plug 2. J Radiol Case Rep 2016;10:44-51. [PMID: 27761198 DOI: 10.3941/jrcr.v10i9.2580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
196 Brooks D, Grewal P, Baine I, Arinsburg SA, Maximos S, Shah NA. Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies. AACE Clin Case Rep 2021;7:307-9. [PMID: 34522770 DOI: 10.1016/j.aace.2021.03.004] [Reference Citation Analysis]
197 Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M, Hagmann M, Blacky A, Ferlitsch A, Sieghart W. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146:1680-1690.e1. [PMID: 24631577 DOI: 10.1053/j.gastro.2014.03.005] [Cited by in Crossref: 245] [Cited by in F6Publishing: 177] [Article Influence: 30.6] [Reference Citation Analysis]
198 Logge WB, Morley KC, Haber PS, Baillie AJ. Executive Functioning Moderates Responses to Appetitive Cues: A Study in Severe Alcohol Use Disorder and Alcoholic Liver Disease. Alcohol and Alcoholism 2019;54:38-46. [DOI: 10.1093/alcalc/agy083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
199 Sommerfeld O, von Loeffelholz C, Diab M, Kiessling S, Doenst T, Bauer M, Sponholz C. Association between high dose catecholamine support and liver dysfunction following cardiac surgery. J Card Surg 2020;35:1228-36. [PMID: 32333454 DOI: 10.1111/jocs.14555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Tandon P, Bishay K, Fisher S, Yelle D, Carrigan I, Wooller K, Kelly E. Comparison of clinical outcomes between variceal and non-variceal gastrointestinal bleeding in patients with cirrhosis: Outcomes of UGIB in cirrhosis. Journal of Gastroenterology and Hepatology 2018;33:1773-9. [DOI: 10.1111/jgh.14147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
201 Gazineo D, Godino L, Bui V, El Mouttaqi L, Franciosi E, Natalino A, Ceci G, Ambrosi E. Health-related quality of life in outpatients with chronic liver disease: a cross-sectional study. BMC Gastroenterol 2021;21:318. [PMID: 34364363 DOI: 10.1186/s12876-021-01890-7] [Reference Citation Analysis]
202 Chen YW, Chang CW, Chang CW, Wang TE, Wu CJ, Chen HH. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 2012; 4(11): 291-298 [PMID: 23293714 DOI: 10.4254/wjh.v4.i11.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
203 Wang YJ, Li JH, Guan Y, Xie QH, Hao CM, Wang ZX. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int 2021;20:215-21. [PMID: 33752999 DOI: 10.1016/j.hbpd.2021.02.006] [Reference Citation Analysis]
204 Goceri E. Automatic labeling of portal and hepatic veins from MR images prior to liver transplantation. Int J Comput Assist Radiol Surg 2016;11:2153-61. [PMID: 27338273 DOI: 10.1007/s11548-016-1446-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
205 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
206 Sucandy I, Giovannetti A, Spence J, Ross S, Rosemurgy A. Does preoperative MELD score affect outcomes following robotic hepatectomy for liver tumors? J Robot Surg 2020;14:725-31. [PMID: 31989441 DOI: 10.1007/s11701-020-01046-x] [Reference Citation Analysis]
207 Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant 2011;25:755-65. [PMID: 21158918 DOI: 10.1111/j.1399-0012.2010.01366.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
208 Mcclune AC, Tong MJ. Is the Search for a Single Comprehensive Staging System for Hepatocellular Carcinoma an Elusive One? Journal of Clinical Gastroenterology 2009;43:697-8. [DOI: 10.1097/mcg.0b013e3181acec0c] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
209 Kinny-Köster B, Bartels M, Becker S, Scholz M, Thiery J, Ceglarek U, Kaiser T. Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease. PLoS One 2016;11:e0159205. [PMID: 27410482 DOI: 10.1371/journal.pone.0159205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
210 Li H, Wang R, Méndez-Sánchez N, Peng Y, Guo X, Qi X. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci 2019;15:434-48. [PMID: 30899297 DOI: 10.5114/aoms.2018.74788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
211 Haimerl M, Poelsterl S, Beyer L, Wiesinger I, Nießen C, Stroszczynski C, Wiggermann P, Jung E, Jung F, Gori T. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. CH 2017;64:435-46. [DOI: 10.3233/ch-168112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
212 Li H, Xia Q, Zeng B, Li ST, Liu H, Li Q, Li J, Yang SY, Dong XJ, Gao T, Munker S, Liu Y, Liebe R, Xue F, Li QG, Chen XS, Liu Q, Zeng H, Wang JY, Xie Q, Meng QH, Wang JF, Mertens PR, Lammert F, Singer MV, Dooley S, Ebert MP, Qiu DK, Wang TL, Weng HL. Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol 2015;63:50-9. [PMID: 25646889 DOI: 10.1016/j.jhep.2015.01.029] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
213 Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12:2901-2908. [PMID: 22822723 DOI: 10.1111/j.1600-6143.2012.04190.x] [Cited by in Crossref: 184] [Cited by in F6Publishing: 146] [Article Influence: 18.4] [Reference Citation Analysis]
214 Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, Azoulay D. Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med. 2016;35:49-57. [PMID: 26477363 DOI: 10.1016/j.accpm.2015.06.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
215 Qi X, Han G, Ye C, Zhang Y, Dai J, Peng Y, Deng H, Li J, Hou F, Ning Z, Zhao J, Zhang X, Wang R, Guo X. Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Med Sci Monit. 2016;22:2528-2550. [PMID: 27432511 DOI: 10.12659/msm.898866] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
216 D'Amico G, Bernardi M, Angeli P. TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. J Hepatol 2021:S0168-8278(21)00438-4. [PMID: 34157322 DOI: 10.1016/j.jhep.2021.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Sundaram V, Choi G, Jeon CY, Ayoub WS, Nissen NN, Klein AS, Tran TT. Donation After Cardiac Death Liver Transplantation in Primary Sclerosing Cholangitis: Proceed With Caution. Transplantation 2015;99:973-8. [DOI: 10.1097/tp.0000000000000447] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
218 Dumitrescu G, Januszkiewicz A, Ågren A, Magnusson M, Wahlin S, Wernerman J. Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation. Medicine (Baltimore) 2017;96:e7101. [PMID: 28591054 DOI: 10.1097/MD.0000000000007101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
219 Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, Moreira R, Elia C, Morales-Ruiz M, Llopis M, Huelin P, Solé C, Fabrellas N, Weiss E, Nevens F, Gerbes A, Trebicka J, Saliba F, Fondevila C, Hernández-Gea V, Fernández J, Bernardi M, Arroyo V, Jiménez W, Deulofeu C, Pavesi M, Angeli P, Jalan R, Moreau R, Sancho-Bru P, Ginès P; CANONIC Investigators, EASL CLIF Consortium. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. J Hepatol 2016;65:57-65. [PMID: 26988732 DOI: 10.1016/j.jhep.2016.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
220 Wendon J, Bernal W, Willars C, Auzinger G. Critical care and cirrhosis: outcome and benefit. Curr Opin Crit Care. 2011;17:533-537. [PMID: 21844797 DOI: 10.1097/MCC.0b013e32834ab06f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
221 Jogo A, Nishida N, Yamamoto A, Kageyama K, Nakano M, Sohgawa E, Hamamoto S, Hamuro M, Miki Y. Selective Balloon-occluded Retrograde Transvenous Obliteration for Gastric Varices. Intern Med 2019;58:2291-7. [PMID: 31118379 DOI: 10.2169/internalmedicine.2356-18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Missiha SB, Ostrowski M, Heathcote EJ. Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors. Gastroenterology 2008;134:1699-714. [DOI: 10.1053/j.gastro.2008.02.069] [Cited by in Crossref: 152] [Cited by in F6Publishing: 127] [Article Influence: 10.9] [Reference Citation Analysis]
223 Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg 2016;53:366-95. [PMID: 27585818 DOI: 10.1067/j.cpsurg.2016.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
224 Li C, Wen T, Yan L, Li B, Yang J, Xu M, Wang W, Wei Y. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Annals of Hepatology 2012;11:471-7. [DOI: 10.1016/s1665-2681(19)31460-7] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
225 Jafri S, Gordon SC. Care of the Cirrhotic Patient. Infectious Disease Clinics of North America 2012;26:979-94. [DOI: 10.1016/j.idc.2012.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
226 Patkar S, Parray A, Mahendra B, Kurunkar S, Goel M. Performance of Hong Kong Liver Cancer staging system in patients of hepatocellular carcinoma treated with surgical resection: An Indian validation study. J Surg Oncol 2019;120:1119-25. [PMID: 31549392 DOI: 10.1002/jso.25704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
227 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int 2011;108:714-20. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
228 Boland BS, Dong MH, Bettencourt R, Barrett-Connor E, Loomba R. Association of serum bilirubin with aging and mortality. J Clin Exp Hepatol. 2014;4:1-7. [PMID: 25328328 DOI: 10.1016/j.jceh.2014.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
229 Hernandez-martinez A, Marin-oyaga VA, Salavati A, Saboury B, Codreanu I, Lam MGEH, Torigian DA, Alavi A. Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study. Ann Nucl Med 2014;28:53-9. [DOI: 10.1007/s12149-013-0780-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
230 Asrani SK, Kamath PS. Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int. 2015;9:346-354. [PMID: 26016462 DOI: 10.1007/s12072-015-9631-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
231 Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Insurance Status But Not Race and Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2021;19:565-572.e5. [PMID: 32389884 DOI: 10.1016/j.cgh.2020.04.081] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011;108:714-720. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714.Epub] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Goralczyk AD, Abu-Ajaj W, Tsui TY, Bauer M, Lorf T, Ramadori G, Obed A. Liver transplantation in patients with liver cirrhosis and active pneumonia: an observational study. Transpl Int 2011;24:1068-74. [PMID: 21883503 DOI: 10.1111/j.1432-2277.2011.01310.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
234 Park HS, Lee JM, Hong K, Han ES, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS. Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience. Ann Hepatobiliary Pancreat Surg 2021;25:336-41. [PMID: 34402433 DOI: 10.14701/ahbps.2021.25.3.336] [Reference Citation Analysis]
235 Surov A, Paul L, Meyer HJ, Schob S, Engelmann C, Wienke A. Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis. J Clin Med. 2018;7:359. [PMID: 30326652 DOI: 10.3390/jcm7100359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
236 Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz RT, Luketic V, Fuchs M, White MB, Bell DE, Gilles H, Morton K, Noble N, Puri P, Sanyal AJ. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646-1653. [PMID: 21556040 DOI: 10.1038/ajg.2011.157] [Cited by in Crossref: 201] [Cited by in F6Publishing: 173] [Article Influence: 18.3] [Reference Citation Analysis]
237 Pezzati D, Ghinolfi D, De Simone P, Balzano E, Filipponi F. Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol 2015; 7(26): 2636-2647 [PMID: 26609341 DOI: 10.4254/wjh.v7.i26.2636] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
238 Cruz-ramírez M, Hervás-martínez C, Fernández JC, Briceño J, de la Mata M. Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks. Artificial Intelligence in Medicine 2013;58:37-49. [DOI: 10.1016/j.artmed.2013.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
239 Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, McPhail MJ, Willars C, Auzinger G, Sizer E, Heneghan M. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54-62. [PMID: 24136710 DOI: 10.1002/lt.23766] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
240 Hasan S, Thai N, Uemura T, Kudithipudi V, Renz P, Abel S, Kirichenko AV. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy. World J Gastrointest Surg 2017; 9(12): 256-263 [PMID: 29359031 DOI: 10.4240/wjgs.v9.i12.256] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
241 Apetauerova D, Hildebrand P, Scala S, Zani JW, Lipert L, Clark E, Fennell T, Gordon FD. A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis. Hepatol Commun 2021;5:323-33. [PMID: 33553978 DOI: 10.1002/hep4.1624] [Reference Citation Analysis]
242 Low G, Alexander GJ, Lomas DJ. Renal impairment in cirrhosis unrelated to hepatorenal syndrome. Can J Gastroenterol Hepatol 2015;29:253-7. [PMID: 25874649 DOI: 10.1155/2015/967683] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
243 Hsu HY, Yu MC, Lee CW, Tsai HI, Sung CM, Chen CW, Huang SW, Lin CY, Jeng WJ, Lee WC, Chen MF. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer. 2017;17:742. [PMID: 29121890 DOI: 10.1186/s12885-017-3748-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
244 Shao J, Liang Y, Li Y, Ding R, Zhu M, You W, Wang Z, Huang B, Wu M, Zhang T, Li K, Wu W, Wu L, Wang Q, Xia X, Wang S, Lu L. Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatol Int. 2021;15:202-212. [PMID: 33548030 DOI: 10.1007/s12072-020-10123-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
245 Mehrotra S, Kilambi V, Bui K, Gilroy R, Alexopoulos SP, Goldberg DS, Ladner DP, Klintmalm GB. A Concentric Neighborhood Solution to Disparity in Liver Access That Contains Current UNOS Districts. Transplantation 2018;102:255-78. [PMID: 28885499 DOI: 10.1097/TP.0000000000001934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
246 Cruz-ramı´rez M, Hervás-martı´nez C, Fernández JC, Briceño J, de la Mata M. Multi-objective evolutionary algorithm for donor–recipient decision system in liver transplants. European Journal of Operational Research 2012;222:317-27. [DOI: 10.1016/j.ejor.2012.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
247 Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD, Friman S, Schrumpf E, Ericzon BG, Höckerstedt K, Karlsen TH. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013. Scand J Gastroenterol 2015;50:797-808. [PMID: 25959101 DOI: 10.3109/00365521.2015.1036359] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
248 Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013;8:e79637. [PMID: 24244533 DOI: 10.1371/journal.pone.0079637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
249 Kim SH, Kim DY, Lim JH, Kim SU, Choi GH, Ahn SH, Choi JS, Kim KS. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg. 2013;83:865-870. [PMID: 22985446 DOI: 10.1111/j.1445-2197.2012.06241.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
250 Gameiro J, Agapito Fonseca J, Monteiro Dias J, Melo MJ, Jorge S, Velosa J, Lopes JA. Prediction of acute kidney injury in cirrhotic patients: a new score combining renal, liver and inflammatory markers. Int J Nephrol Renovasc Dis 2018;11:149-54. [PMID: 29731657 DOI: 10.2147/IJNRD.S163602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
251 Arroyo V, Moreau R, Jalan R, Gines P. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol. 2015;S131-S143. [PMID: 25920082 DOI: 10.1016/j.jhep.2014.11.045] [Cited by in Crossref: 244] [Cited by in F6Publishing: 190] [Article Influence: 40.7] [Reference Citation Analysis]
252 Mercurio I, Ceraso G, Melai P, Gili A, Troiano G, Agostinelli F, Lancia M, Bacci M. Significance of Morphine Concentration in Bile, Liver, and Blood: Analysis of 52 Cases of Heroin Overdoses. Am J Forensic Med Pathol 2019;40:329-35. [DOI: 10.1097/paf.0000000000000508] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
253 Bachir NM, Larson AM. Adult liver transplantation in the United States. Am J Med Sci. 2012;343:462-469. [PMID: 22683615 DOI: 10.1097/maj.0b013e3182308b66] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
254 Huang R, Yang C, Wu K, Cao S, Liu Y, Su R, Xiong Y, Huang A, Wu C. Red cell distribution width as a potential index to assess the severity of hepatitis B virus-related liver diseases. Hepatol Res. 2014;44:E464-E470. [PMID: 24720373 DOI: 10.1111/hepr.12342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
255 Yu Z, Zhang Y, Cao Y, Xu M, You S, Chen Y, Zhu B, Kong M, Song F, Xin S, Duan Z, Han T. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep 2021;11:1810. [PMID: 33469110 DOI: 10.1038/s41598-021-81431-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
256 Pommergaard HC, Rostved AA, Adam R, Rasmussen A, Salizzoni M, Bravo MAG, Cherqui D, De Simone P, Houssel-Debry P, Mazzaferro V, Soubrane O, García-Valdecasas JC, Prous JF, Pinna AD, O'Grady J, Karam V, Duvoux C, Thygesen LC. Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry. Liver Cancer 2020;9:455-67. [PMID: 32999871 DOI: 10.1159/000507397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 McPhail MJW, Shawcross DL, Lewis MR, Coltart I, Want EJ, Antoniades CG, Veselkov K, Triantafyllou E, Patel V, Pop O, Gomez-Romero M, Kyriakides M, Zia R, Abeles RD, Crossey MME, Jassem W, O'Grady J, Heaton N, Auzinger G, Bernal W, Quaglia A, Coen M, Nicholson JK, Wendon JA, Holmes E, Taylor-Robinson SD. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis. J Hepatol. 2016;64:1058-1067. [PMID: 26795831 DOI: 10.1016/j.jhep.2016.01.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
258 Zhou YF, Zhou YJ, Ye FZ, Liu WY, Zheng MH. A Novel Use of Model for End-Stage Liver Disease (MELD) Score in Guiding Therapeutic Antibiotics Choice for Critically Ill Cirrhotic Patients. Med Sci Monit 2019;25:5005-14. [PMID: 31278890 DOI: 10.12659/MSM.914409] [Reference Citation Analysis]
259 Takaoka Y, Miura K, Morimoto N, Ikegami T, Kakizaki S, Sato K, Ueno T, Naganuma A, Kosone T, Arai H, Hatanaka T, Tahara T, Tano S, Ohtake T, Murohisa T, Namikawa M, Asano T, Kamoshida T, Horiuchi K, Nihei T, Soeda A, Kurata H, Fujieda T, Ohtake T, Fukaya Y, Iijima M, Watanabe S, Isoda N, Yamamoto H; Liver Investigators in the Northern Kanto Study (LINKS) group. Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. Hepatol Res 2021;51:51-61. [PMID: 33021009 DOI: 10.1111/hepr.13576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
260 Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D'Ambrosio D, Gioia S, Ginanni Corradini S, Lucidi C, Mennini G, Rossi M, Merli M, Riggio O. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. Dig Liver Dis 2019;51:1508-12. [PMID: 31601536 DOI: 10.1016/j.dld.2019.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
261 Xu Y, Li N, Lu M, Myers RP, Dixon E, Walker R, Sun L, Zhao X, Quan H. Development and validation of method for defining conditions using Chinese electronic medical record. BMC Med Inform Decis Mak 2016;16:110. [PMID: 27542973 DOI: 10.1186/s12911-016-0348-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
262 Adachi M, Tanaka A, Aiso M, Takamori Y, Takikawa H. Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis. Hepatol Res. 2015;45:1299-1306. [PMID: 25704216 DOI: 10.1111/hepr.12508] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
263 Egbe AC, Miranda WR, Veldtman GR, Graham RP, Kamath PS. Hepatic Venous Pressure Gradient in Fontan Physiology Has Limited Diagnostic and Prognostic Significance. CJC Open 2020;2:360-4. [PMID: 32995721 DOI: 10.1016/j.cjco.2020.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg. 2009;33:2412-2419. [PMID: 19756859 DOI: 10.1007/s00268-009-0202-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
265 Dietrich CG, Götze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016; 22(1): 72-88 [PMID: 26755861 DOI: 10.3748/wjg.v22.i1.72] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
266 Pang JX, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, Shaheen AA, Coffin CS, Heitman SJ, Kaplan GG, Swain MG, Myers RP. Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. PLoS One 2014;9:e95776. [PMID: 24755824 DOI: 10.1371/journal.pone.0095776] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
267 Kaiser T, Kinny-Köster B, Bartels M, Parthaune T, Schmidt M, Thiery J. Impact of different creatinine measurement methods on liver transplant allocation. PLoS One 2014;9:e90015. [PMID: 24587188 DOI: 10.1371/journal.pone.0090015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
268 Grünhage F, Mahler M, Reichel C, Lammert F. Extremely low vitamin d levels are associated with increased mortality in patients with liver cirrhosis. J Hepatol. 2012;56:S247. [PMID: 24236541 DOI: 10.1111/eci.12205] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
269 Abbas N, Makker J, Abbas H, Balar B. Perioperative Care of Patients With Liver Cirrhosis: A Review. Health Serv Insights 2017;10:1178632917691270. [PMID: 28469455 DOI: 10.1177/1178632917691270] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
270 Duan T, Jiang H, Xia C, Chen J, Cao L, Ye Z, Wei Y, Song B, Lee JM. Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI. Front Med (Lausanne) 2020;7:215. [PMID: 32549039 DOI: 10.3389/fmed.2020.00215] [Reference Citation Analysis]
271 Salahshour F, Mehrabinejad MM, Rashidi Shahpasandi MH, Salahshour M, Shahsavari N, Nassiri Toosi M, Ayoobi Yazdi N. Esophageal variceal hemorrhage: the role of MDCT characteristics in predicting the presence of varices and bleeding risk. Abdom Radiol (NY) 2020;45:2305-14. [PMID: 32447415 DOI: 10.1007/s00261-020-02585-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Xu MM, Kong M, Yu PF, Cao YY, Liu F, Zhu B, Zhang YZ, Lu W, Zou HB, Duan BW, You SL, Xin SJ, Han T, Duan ZP, Chen Y. Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study. J Clin Transl Hepatol 2021;9:626-34. [PMID: 34722177 DOI: 10.14218/JCTH.2020.00179] [Reference Citation Analysis]
273 Chen RC, Cai YJ, Wu JM, Wang XD, Song M, Wang YQ, Zheng MH, Chen YP, Lin Z, Shi KQ. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis. J Viral Hepat 2017;24:238-45. [PMID: 27862671 DOI: 10.1111/jvh.12638] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
274 Berni ER, Jones BI, Berni TR, Whitehouse J, Hudson M, Orr J, Conway P, Amlani B, Currie CJ. The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC). PLoS One 2019;14:e0223253. [PMID: 31581237 DOI: 10.1371/journal.pone.0223253] [Reference Citation Analysis]
275 Darweesh SK, Yosry A, Salah M, Zayed N, Khairy A, Awad A, Mabrouk M, Albuhairi A. Acoustic radiation forced impulse-based splenic prediction model using data mining for the noninvasive prediction of esophageal varices in hepatitis C virus advanced fibrosis. Eur J Gastroenterol Hepatol 2019;31:1533-9. [PMID: 31689264 DOI: 10.1097/MEG.0000000000001458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
276 Bayer F, Audry B, Antoine C, Jasseron C, Legeai C, Bastien O, Jacquelinet C. Removing administrative boundaries using a gravity model for a national liver allocation system. Am J Transplant 2021;21:1080-91. [PMID: 32659870 DOI: 10.1111/ajt.16214] [Reference Citation Analysis]
277 Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. Eur J Clin Invest. 2009;39:65-71. [PMID: 19087131 DOI: 10.1111/j.1365-2362.2008.02063.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
278 Remmler J, Schneider C, Treuner-Kaueroff T, Bartels M, Seehofer D, Scholz M, Berg T, Kaiser T. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2018;16:730-737. [PMID: 28919544 DOI: 10.1016/j.cgh.2017.09.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
279 Boone MD, Celi LA, Ho BG, Pencina M, Curry MP, Lior Y, Talmor D, Novack V. Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. J Crit Care. 2014;29:881.e7-881.13. [PMID: 24974049 DOI: 10.1016/j.jcrc.2014.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
280 Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TR. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013;144:1024-30. [PMID: 23333348 DOI: 10.1053/j.gastro.2013.01.021] [Cited by in Crossref: 125] [Cited by in F6Publishing: 121] [Article Influence: 13.9] [Reference Citation Analysis]
281 Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, Breguet R, Lanthier N, Farina A, Passweg J. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013;8:e53719. [PMID: 23341981 DOI: 10.1371/journal.pone.0053719] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
282 Shearn CT, Orlicky DJ, Petersen DR. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Exp Mol Pathol 2018;104:1-8. [PMID: 29180269 DOI: 10.1016/j.yexmp.2017.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
283 van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. Am J Transplant 2016;16:2277-92. [PMID: 26813115 DOI: 10.1111/ajt.13732] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 26.5] [Reference Citation Analysis]
284 Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DE. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61:1158-1165. [PMID: 25010259 DOI: 10.1016/j.jhep.2014.06.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 8.5] [Reference Citation Analysis]
285 Mariante-Neto G, Brandão AB. Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females? Transplantation 2015;99:2337-40. [PMID: 26177085 DOI: 10.1097/TP.0000000000000747] [Reference Citation Analysis]
286 Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434-443. [PMID: 22271656 DOI: 10.1002/lt.23394] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 10.7] [Reference Citation Analysis]
287 Dhir M, Melin AA, Douaiher J, Lin C, Zhen WK, Hussain SM, Geschwind JF, Doyle MB, Abou-Alfa GK, Are C. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma. Ann Surg. 2016;263:1112-1125. [PMID: 26813914 DOI: 10.1097/sla.0000000000001556] [Cited by in Crossref: 124] [Cited by in F6Publishing: 86] [Article Influence: 24.8] [Reference Citation Analysis]
288 Bala L, Mehrotra M, Mohindra S, Saxena R, Khetrapal CL. Early prognostic markers for fatal fulminant hepatic failure cases with viral hepatitis: Proton nuclear magnetic resonance spectroscopic studies of serum. Digestive and Liver Disease 2013;45:155-63. [DOI: 10.1016/j.dld.2012.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
289 Zhao TY, Cong QW, Liu F, Yao LY, Zhu Y. Nonlinear Relationship Between Macrocytic Anemia and Decompensated Hepatitis B Virus Associated Cirrhosis: A Population-Based Cross-Sectional Study. Front Pharmacol 2021;12:755625. [PMID: 34616304 DOI: 10.3389/fphar.2021.755625] [Reference Citation Analysis]
290 Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-173, 173. e1. [PMID: 21893129 DOI: 10.1016/j.cgh.2011.08.028] [Cited by in Crossref: 444] [Cited by in F6Publishing: 424] [Article Influence: 40.4] [Reference Citation Analysis]
291 Härmälä S, O'Brien A, Parisinos CA, Direk K, Shallcross L, Hayward A. Development and validation of a prediction model to estimate the risk of liver cirrhosis in primary care patients with abnormal liver blood test results: protocol for an electronic health record study in Clinical Practice Research Datalink. Diagn Progn Res 2019;3:10. [PMID: 31143841 DOI: 10.1186/s41512-019-0056-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
292 Younossi ZM, Stepanova M, Lawitz E, Charlton M, Loomba R, Myers RP, Subramanian M, Mchutchison JG, Goodman Z. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver Int 2018;38:1849-59. [DOI: 10.1111/liv.13706] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
293 Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology. 2017;283:280-292. [PMID: 27797679 DOI: 10.1148/radiol.2016152641] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
294 Li J, Hu C, Chen Y, Zhang R, Fu S, Zhou M, Gao Z, Fu M, Yan T, Yang Y, Li J, Liu J, Chen T, Zhao Y, He Y. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B. BMC Infect Dis 2021;21:567. [PMID: 34126939 DOI: 10.1186/s12879-021-06237-x] [Reference Citation Analysis]
295 Briceño J, Cruz-Ramírez M, Prieto M, Navasa M, Ortiz de Urbina J, Orti R, Gómez-Bravo MÁ, Otero A, Varo E, Tomé S, Clemente G, Bañares R, Bárcena R, Cuervas-Mons V, Solórzano G, Vinaixa C, Rubín A, Colmenero J, Valdivieso A, Ciria R, Hervás-Martínez C, de la Mata M. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. J Hepatol 2014;61:1020-8. [PMID: 24905493 DOI: 10.1016/j.jhep.2014.05.039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
296 Cai YJ, Dong JJ, Dong JZ, Chen Y, Lin Z, Song M, Wang YQ, Chen YP, Shi KQ, Zhou MT. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45:1413-1426. [PMID: 28345155 DOI: 10.1111/apt.14046] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
297 Park HS, Desser TS, Jeffrey RB, Kamaya A. Doppler Ultrasound in Liver Cirrhosis: Correlation of Hepatic Artery and Portal Vein Measurements With Model for End-Stage Liver Disease Score: Doppler Ultrasound in Liver Cirrhosis. J Ultrasound Med 2017;36:725-30. [DOI: 10.7863/ultra.16.03107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
298 Bandali A, Bias TE, Lee DH, Malat G. Duration of Perioperative Antimicrobial Prophylaxis in Orthotopic Liver Transplantation Patients. Prog Transplant 2020;30:265-70. [PMID: 32597322 DOI: 10.1177/1526924820933824] [Reference Citation Analysis]
299 Arjal R, Trotter JF. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis. 2009;13:67-71. [PMID: 19150311 DOI: 10.1016/j.cld.2008.09.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
300 Pérez-ortiz M, Gutiérrez P, Ayllón-terán M, Heaton N, Ciria R, Briceño J, Hervás-martínez C. Synthetic semi-supervised learning in imbalanced domains: Constructing a model for donor-recipient matching in liver transplantation. Knowledge-Based Systems 2017;123:75-87. [DOI: 10.1016/j.knosys.2017.02.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
301 Umino R, Kobayashi Y, Akabane M, Kojima K, Okubo S, Hashimoto M, Shindoh J. Preoperative nutritional score predicts underlying liver status and surgical risk of hepatocellular carcinoma. Scand J Surg 2021;:14574969211061953. [PMID: 34931568 DOI: 10.1177/14574969211061953] [Reference Citation Analysis]
302 Mrzljak A, Franusic L, Pavicic-Saric J, Kelava T, Jurekovic Z, Kocman B, Mikulic D, Budimir-Bekan I, Knotek M. Pre- and intraoperative predictors of acute kidney injury after liver transplantation. World J Clin Cases 2020; 8(18): 4034-4042 [PMID: 33024760 DOI: 10.12998/wjcc.v8.i18.4034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
303 Elhence A, Vaishnav M, Biswas S, Anand A, Gunjan D, Kedia S, Mahapatra SJ, Nayak B, Sheikh S, Soni KD, Trikha A, Goel A, Shalimar. Predictors of in-hospital outcomes in patients with Cirrhosis and Coronavirus disease-2019. J Clin Exp Hepatol 2021. [PMID: 34728983 DOI: 10.1016/j.jceh.2021.10.014] [Reference Citation Analysis]
304 Stravitz RT, Ilan Y. Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic? Liver Int 2017;37:328-36. [DOI: 10.1111/liv.13268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
305 Saleh DO, Mansour DF, Hashad IM, Bakeer RM. Effects of sulforaphane on D-galactose-induced liver aging in rats: Role of keap-1/nrf-2 pathway. Eur J Pharmacol 2019;855:40-9. [PMID: 31039346 DOI: 10.1016/j.ejphar.2019.04.043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
306 Koo JK, Kim JH, Choi YJ, Lee CI, Yang JH, Yoon HY, Choi HJ, Ko SY, Choe WH, Kwon SY, Lee CH. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis: Value of Refit Model for End-stage Liver Disease. J Gastroenterol Hepatol 2013;28:1209-16. [DOI: 10.1111/jgh.12156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
307 Chou HW, Lin MH, Chen YS, Yu HY. Impact of MELD score and cardiopulmonary bypass duration on post-operative hypoxic hepatitis in patients with liver cirrhosis undergoing open heart surgery. J Formos Med Assoc 2020;119:838-44. [PMID: 31530414 DOI: 10.1016/j.jfma.2019.08.028] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
308 Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, Durand F, Valla D, Lebrec D, Moreau R. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010;30:725-32. [PMID: 20040048 DOI: 10.1111/j.1478-3231.2009.02182.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 88] [Article Influence: 8.5] [Reference Citation Analysis]
309 Ashktorab H, Panchal H, Shokrani B, Paydar M, Sanderson A, Lee EL, Begum R, Haidary T, Laiyemo AO, McDonald-Pinkett S, Brim H, Nouraie M. Association between Diverticular Disease and Pre-Neoplastic Colorectal Lesions in an Urban African-American Population. Digestion 2015;92:60-5. [PMID: 26183208 DOI: 10.1159/000376574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
310 De Gottardi J, Montani M, Angelillo-Scherrer A, Rovo A, Berzigotti A. Hepatic sinusoidal hemophagocytosis with and without hemophagocytic lymphohistiocytosis. PLoS One 2019;14:e0226899. [PMID: 31887162 DOI: 10.1371/journal.pone.0226899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
311 Cerqueira de Carvalho G, de Andrade Regis C, Rosário Kalil J, Aparício Cerqueira L, Silva Barbosa D, Pamponet Motta M, da Silva Nery M, Alice Pires Soares M, Celestino Zollinger C, Lisboa Bittencourt P. Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality. Annals of Hepatology 2012;11:90-5. [DOI: 10.1016/s1665-2681(19)31491-7] [Cited by in Crossref: 28] [Article Influence: 2.8] [Reference Citation Analysis]
312 Kim GY, Bae KS, Noh GJ, Min WK. Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin, and albumin. J Hepatobiliary Pancreat Surg 2009;16:521-8. [DOI: 10.1007/s00534-009-0097-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
313 Wang WJ, Lai RT, Lu J, Xiang XG, Zhao GD, Tang WL, Cai W, Wang H, Zhou HJ, Xie Q. Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure. J Dig Dis. 2016;17:334-339. [PMID: 27059663 DOI: 10.1111/1751-2980.12348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
314 Koay EJ, Owen D, Das P. Radiation-Induced Liver Disease and Modern Radiotherapy. Semin Radiat Oncol 2018;28:321-31. [PMID: 30309642 DOI: 10.1016/j.semradonc.2018.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
315 Ciccocioppo R, Dos Santos CC, Baumgart DC, Cangemi GC, Cardinale V, Ciacci C, De Coppi P, Haldar D, Klersy C, Nostro MC, Ott M, Piemonti L, Tomei AA, Uygun B, Vetrano S, Orlando G. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017. Cytotherapy 2018;20:461-76. [PMID: 29398624 DOI: 10.1016/j.jcyt.2017.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Shearn CT, Saba LM, Roede JR, Orlicky DJ, Shearn AH, Petersen DR. Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. Free Radic Biol Med 2017;113:280-90. [PMID: 28988798 DOI: 10.1016/j.freeradbiomed.2017.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
317 Malinowski M, Jara M, Lüttgert K, Orr J, Lock JF, Schott E, Stockmann M. Enzymatic Liver Function Capacity Correlates with Disease Severity of Patients with Liver Cirrhosis: A Study with the LiMAx Test. Dig Dis Sci 2014;59:2983-91. [DOI: 10.1007/s10620-014-3250-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
318 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 26.5] [Reference Citation Analysis]
319 Peguero A, Herraiz I, Perales A, Melchor JC, Melchor I, Marcos B, Villalain C, Martinez-Portilla R, Mazarico E, Meler E, Hernandez S, Matas I, Del Rio M, Galindo A, Figueras F. Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial. Am J Obstet Gynecol 2021;225:308.e1-308.e14. [PMID: 33823150 DOI: 10.1016/j.ajog.2021.03.044] [Reference Citation Analysis]
320 Roth JA, Widmer AF, Tschudin-Sutter S, Dangel M, Frei R, Battegay M, Hug BL. The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study. PLoS One 2017;12:e0175669. [PMID: 28414786 DOI: 10.1371/journal.pone.0175669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
321 Ra G, Tsien C, Renner EL, Wong FS. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites. Journal of Clinical Gastroenterology 2015;49:858-65. [DOI: 10.1097/mcg.0000000000000311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
322 Stonington SD. On ethical locations: The good death in Thailand, where ethics sit in places. Social Science & Medicine 2012;75:836-44. [DOI: 10.1016/j.socscimed.2012.03.045] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
323 Alexopoulos T, Vasilieva L, Kontogianni MD, Tenta R, Georgiou A, Stroumpouli E, Mani I, Alexopoulou A. Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia. Am J Physiol Gastrointest Liver Physiol 2021;321:G543-51. [PMID: 34469188 DOI: 10.1152/ajpgi.00184.2021] [Reference Citation Analysis]
324 Mendoza N, Rivas E, Rodriguez-Roisin R, Garcia T, Bruguera M, Agusti A, Faner R. Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study. PLoS One 2021;16:e0245046. [PMID: 33630849 DOI: 10.1371/journal.pone.0245046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Ariza X, Solà E, Elia C, Barreto R, Moreira R, Morales-Ruiz M, Graupera I, Rodríguez E, Huelin P, Solé C. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS One. 2015;10:e0128145. [PMID: 26042740 DOI: 10.1371/journal.pone.0128145] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
326 Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD. Palliative care in end-stage liver disease: Time to do better? Liver Transpl 2018;24:961-8. [PMID: 29729119 DOI: 10.1002/lt.25193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
327 Lui JK, Spaho L, Hakimian S, Devine M, Bui R, Touray S, Holzwanger E, Patel B, Ellis D, Fridlyand S, Ogunsua AA, Mahboub P, Daly JS, Bozorgzadeh A, Kopec SE. Pleural Effusions Following Liver Transplantation: A Single-Center Experience. J Intensive Care Med 2021;36:862-72. [PMID: 32527176 DOI: 10.1177/0885066620932448] [Reference Citation Analysis]
328 Hong G, Lee KW, Suh S, Yoo T, Kim H, Park MS, Choi Y, Yi NJ, Suh KS. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci. 2013;28:1207-1212. [PMID: 23960449 DOI: 10.3346/jkms.2013.28.8.1207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
329 Legaz I, Navarro-Noguera E, Bolarín JM, García-Alonso AM, Luna Maldonado A, Mrowiec A, Campillo JA, Gimeno L, Moya-Quiles R, Álvarez-López Mdel R, Minguela Puras A, Miras M, Sánchez-Bueno F, Muro M. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain. Alcohol Clin Exp Res 2016;40:794-805. [PMID: 27012317 DOI: 10.1111/acer.13013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
330 Gao F, Li X, Wan G, Li Y, Zhang Q, Liu Y, Liu H, Li H, Wang X. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. BMC Gastroenterol. 2018;18:179. [PMID: 30509201 DOI: 10.1186/s12876-018-0911-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
331 Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010;52:523-528. [PMID: 20185195 DOI: 10.1016/j.jhep.2010.01.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
332 Cheng X SM, Kim W, Tan J. Utility in treating renal failure in end-stage liver disease with simultaneous liver-kidney transplantation. Transplantation. 2016;. [PMID: 28437790 DOI: 10.1097/tp.0000000000001491] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
333 Lemyze M, Dharancy S, Nevière R, Wallaert B. Cardiopulmonary response to exercise in patients with liver cirrhosis and impaired pulmonary gas exchange. Respir Med. 2011;105:1550-1556. [PMID: 21764574 DOI: 10.1016/j.rmed.2011.06.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
334 Chan K, Yeh J, Sun W. The role of autonomic dysfunction in predicting 1-year mortality after liver transplantation. Liver Int 2017;37:1239-48. [DOI: 10.1111/liv.13364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
335 Asrani SK, Kamath PS. Prediction of early mortality after variceal bleeding: score one more for MELD. Gastroenterology 2014;146:337-9. [PMID: 24361433 DOI: 10.1053/j.gastro.2013.12.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
336 Peguero A, Fernandez-Blanco L, Mazarico E, Benitez L, Gonzalez A, Youssef L, Crispi F, Hernandez S, Figueras F. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study. BJOG 2021;128:158-65. [PMID: 32593222 DOI: 10.1111/1471-0528.16383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
337 Day E, Best D, Sweeting R, Russell R, Webb K, Georgiou G, Neuberger J. Predictors of psychological morbidity in liver transplant assessment candidates: is alcohol abuse or dependence a factor? Transpl Int. 2009;22:606-614. [PMID: 19207190 DOI: 10.1111/j.1432-2277.2009.00835.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
338 van Roekel C, Reinders MT, van der Velden S, Lam MG, Braat MN. Hepatobiliary Imaging in Liver-directed Treatments. Seminars in Nuclear Medicine 2019;49:227-36. [DOI: 10.1053/j.semnuclmed.2019.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Metcalfe EL, Avenell A, Fraser A. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review. Clin Nutr. 2014;33:958-965. [PMID: 24656171 DOI: 10.1016/j.clnu.2014.02.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
340 Grossmann M, Hoermann R, Gani L, Chan I, Cheung A, Gow PJ, Li A, Zajac JD, Angus P. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin Endocrinol (Oxf). 2012;77:323-328. [PMID: 22280063 DOI: 10.1111/j.1365-2265.2012.04347.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
341 Lim KH, Potts JR, Chetwood J, Goubet S, Verma S. Long-term outcomes after hospitalization with spontaneous bacterial peritonitis. J Dig Dis. 2015;16:228-240. [PMID: 25564761 DOI: 10.1111/1751-2980.12228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
342 Nielsen JK, Olafsson S, Bergmann OM, Runarsdottir V, Hansdottir I, Sigurdardottir R, Björnsson ES. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease. Scand J Gastroenterol 2017;52:762-7. [PMID: 28276826 DOI: 10.1080/00365521.2017.1295466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
343 Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-khac E, Duhamel C, Lebrec D, Poynard T, Moreau R. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007;46:1872-82. [DOI: 10.1002/hep.21920] [Cited by in Crossref: 168] [Cited by in F6Publishing: 154] [Article Influence: 11.2] [Reference Citation Analysis]
344 Obradovic M, Gluvic Z, Petrovic N, Obradovic M, Tomasevic R, Dugalic P, Isenovic ER. A quality of life assessment and the correlation between generic and disease-specific questionnaires scores in outpatients with chronic liver disease-pilot study. Rom J Intern Med 2017;55:129-37. [PMID: 28323622 DOI: 10.1515/rjim-2017-0014] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
345 Sakai T, Matsusaki T, Dai F, Tanaka KA, Donaldson JB, Hilmi IA, Wallis Marsh J, Planinsic RM, Humar A. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth. 2012;108:469-477. [PMID: 22174347 DOI: 10.1093/bja/aer392] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
346 Ronald J, Rao R, Choi SS, Kappus M, Martin JG, Sag AA, Pabon-Ramos WM, Suhocki PV, Smith TP, Kim CY. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites. Cardiovasc Intervent Radiol. 2019;42:720-728. [PMID: 30603968 DOI: 10.1007/s00270-018-02155-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
347 Huang GQ, Xie YY, Zhu PW, Wang XD, Lin Z, Wang Y, Ye JP, Wang YM, Chen YX, Jin XZ, Van Poucke S, Chen YP, Zheng MH. Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure. Expert Rev Gastroenterol Hepatol 2018;12:295-302. [PMID: 29300103 DOI: 10.1080/17474124.2018.1424540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
348 Srungaram P, Rule JA, Yuan HJ, Reimold A, Dahl B, Sanders C, Lee WM. Plasma osteopontin in acute liver failure. Cytokine. 2015;73:270-276. [PMID: 25802196 DOI: 10.1016/j.cyto.2015.02.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
349 Kim J, Choi J, Kwon J, Jang J, Bae S, Yoon S, You Y, Kim D. Performance of Posttransplant Model for End-Stage Liver Disease (MELD) and Delta-MELD Scores on Short-Term Outcome After Living Donor Liver Transplantation. Transplantation Proceedings 2009;41:3766-8. [DOI: 10.1016/j.transproceed.2009.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
350 Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-27. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
351 Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584-590. [PMID: 25846824 DOI: 10.1002/hep.27830] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 14.9] [Reference Citation Analysis]
352 Ferrández O, Urbina O, Grau S, Mateu-de-Antonio J, Marin-Casino M, Portabella J, Mojal S, Riu M, Salas E. Computerized pharmacy surveillance and alert system for drug-related problems. J Clin Pharm Ther 2017;42:201-8. [PMID: 28078665 DOI: 10.1111/jcpt.12495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
353 Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, Dai J, Hou F, Zhao J, Wang R, Guo X. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol 2016;10:971-80. [PMID: 27070325 DOI: 10.1080/17474124.2016.1177788] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
354 Li Y, Han B, Li H, Song T, Bao W, Wang R, Bai Z, Zheng K, Li Q, Guo X, Qi X. Effect of Admission Time on the Outcomes of Liver Cirrhosis with Acute Upper Gastrointestinal Bleeding: Regular Hours versus Off-Hours Admission. Can J Gastroenterol Hepatol 2018;2018:3541365. [PMID: 30631756 DOI: 10.1155/2018/3541365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
355 Wiegand LR, Brandes SB. The UREThRAL stricture score: A novel method for describing anterior urethral strictures. Can Urol Assoc J 2012;6:260-4. [PMID: 23093535 DOI: 10.5489/cuaj.12048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
356 Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
357 Giannini EG, Greco A, Marenco S, Andorno E, Valente U, Savarino V. Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010;8:899-902; quiz e109. [PMID: 20601131 DOI: 10.1016/j.cgh.2010.06.018] [Cited by in Crossref: 103] [Cited by in F6Publishing: 80] [Article Influence: 8.6] [Reference Citation Analysis]
358 Bajaj JS, Thacker LR, Fagan A, White MB, Gavis EA, Hylemon PB, Brown R, Acharya C, Heuman DM, Fuchs M, Dalmet S, Sikaroodi M, Gillevet PM. Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis. JCI Insight 2018;3:98019. [PMID: 29515036 DOI: 10.1172/jci.insight.98019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
359 Ganesh S, Rogal SS, Yadav D, Humar A, Behari J. Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One. 2013;8:e55140. [PMID: 23383085 DOI: 10.1371/journal.pone.0055140] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
360 Naqvi IH, Talib A, Mahmood K, Abidi R, Rizvi SNZ. The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics. Prz Gastroenterol 2019;14:250-7. [PMID: 31988671 DOI: 10.5114/pg.2019.83872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Alqahtani SA, Larson AM. Adult liver transplantation in the USA: . Current Opinion in Gastroenterology 2011;27:240-7. [DOI: 10.1097/mog.0b013e3283457d5d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
362 Bai Z, Primignani M, Guo X, Zheng K, Li H, Qi X. Incidence and mortality of renal dysfunction in cirrhotic patients with acute gastrointestinal bleeding: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2019;13:1181-8. [PMID: 31736376 DOI: 10.1080/17474124.2019.1694904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
363 Younossi ZM, Stepanova M, Saab S, Ahmed A, Lam B, Srishord M, Venkatesan C, Wai H, Henry L. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes. J Viral Hepat. 2015;Aug 20; Epub ahead of print. [PMID: 26289820 DOI: 10.1111/jvh.12449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
364 Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am. 2011;40:611-639. [PMID: 21893277 DOI: 10.1016/j.gtc.2011.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
365 Lin KH, Liu JW, Chen CL, Wang SH, Lin CC, Liu YW, Yong CC, Lin TL, Li WF, Hu TH, Wang CC. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation. PLoS One 2013;8:e72893. [PMID: 24023787 DOI: 10.1371/journal.pone.0072893] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
366 Plevris N, Sinha R, Hay AW, McDonald N, Plevris JN, Hayes PC. Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease. Aliment Pharmacol Ther. 2018;48:423-430. [PMID: 29971829 DOI: 10.1111/apt.14897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
367 Uchiyama H, Shimada M, Imura S, Morine Y, Kanemura H, Arakawa Y, Kanamoto M, Nishi M, Hanaoka J. Living donor liver transplantation using a left hepatic graft from a donor with a history of gastric cancer operation. Transpl Int 2010;23:234-5. [PMID: 19659795 DOI: 10.1111/j.1432-2277.2009.00920.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
368 Tang D, Yan M, Song BL, Zhao YC, Xiao YW, Wang F, Liang W, Zhang BK, Chen XJ, Zou JJ, Tian Y, Wang WL, Jiang YF, Gong GZ, Zhang M, Xiang DX. Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study. Br J Clin Pharmacol 2021;87:1890-902. [PMID: 33010043 DOI: 10.1111/bcp.14578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
369 Vargas Abello LM, Klein AL, Marwick TH, Nowicki ER, Rajeswaran J, Puwanant S, Blackstone EH, Pettersson GB. Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease. The Journal of Thoracic and Cardiovascular Surgery 2013;145:1234-1241.e5. [DOI: 10.1016/j.jtcvs.2012.01.088] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
370 Rogalski P, Rogalska-Plonska M, Wroblewski E, Kostecka-Roslen I, Dabrowska M, Swidnicka-Siergiejko A, Wasielica-Berger J, Cydzik M, Hirnle T, Dobrzycki S, Flisiak R, Dabrowski A. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history. Scand J Gastroenterol 2019;54:311-8. [PMID: 30907172 DOI: 10.1080/00365521.2019.1578822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
371 Park JG, Tak WY, Park SY, Kweon YO, Jang SY, Lee YR, Bae SH, Jang JY, Kim DY, Lee JS, Suk KT, Kim IH, Lee HJ, Chung WJ, Jang BK, Suh JI, Heo J, Lee WK. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine (Baltimore) 2017;96:e6580. [PMID: 28614215 DOI: 10.1097/MD.0000000000006580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
372 Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, Alavian SM. The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review Article. Anesth Pain Med 2016;6:e37822. [PMID: 27843779 DOI: 10.5812/aapm.37822] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
373 Zhang X, Qi X, Yoshida EM, Méndez-Sánchez N, Hou F, Deng H, Wang X, Qiu J, He C, Wang S, Guo X. Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes. Eur J Gastroenterol Hepatol 2018;30:233-40. [PMID: 29189394 DOI: 10.1097/MEG.0000000000001011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
374 Becker S, Kinny-Köster B, Bartels M, Scholz M, Seehofer D, Berg T, Engelmann C, Thiery J, Ceglarek U, Kaiser T. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis. PLoS One 2017;12:e0174424. [PMID: 28334008 DOI: 10.1371/journal.pone.0174424] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
375 Liu Y, Han T, Zhu Z, Li Y. Thymosinβ4: A novel assessed biomarker of the prognosis of acute-on-chronic liver failure patient? Clinics and Research in Hepatology and Gastroenterology 2014;38:310-7. [DOI: 10.1016/j.clinre.2014.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
376 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Reference Citation Analysis]
377 Gao F, Wang R, Deng H, Hou F, Romeiro FG, Qi X. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis. Postgraduate Medicine 2017;129:756-61. [DOI: 10.1080/00325481.2017.1327781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
378 Jiang C, Wang Z, Xu Q, Wu X, Ding Y. Inferior Right Hepatic Vein-preserving Major Right Hepatectomy for Hepatocellular Carcinoma in Patients with Significant Fibrosis or Cirrhosis. World J Surg. 2014;38:159-167. [PMID: 24081537 DOI: 10.1007/s00268-013-2240-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
379 Li H, Chen LY, Zhang NN, Li ST, Zeng B, Pavesi M, Amorós À, Mookerjee RP, Xia Q, Xue F, Ma X, Hua J, Sheng L, Qiu DK, Xie Q, Foster GR, Dusheiko G, Moreau R, Gines P, Arroyo V, Jalan R. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Sci Rep. 2016;6:25487. [PMID: 27146801 DOI: 10.1038/srep25487] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
380 Kim TH, Um SH, Yim SY, Seo YS, Yim HJ, Jeen YT, Lee HS, Chun HJ, Kim CD, Ahn H, Lee Y. The risk of perioperative adverse events in patients with chronic liver disease. Liver Int. 2015;35:713-723. [PMID: 24620863 DOI: 10.1111/liv.12529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
381 Qazi Arisar FA, Abid S, Shaikh PA, Awan S. Impact of sepsis and non-communicable diseases on prognostic models to predict the outcome of hospitalized chronic liver disease patients. World J Hepatol 2018; 10(12): 944-955 [PMID: 30631399 DOI: 10.4254/wjh.v10.i12.944] [Reference Citation Analysis]
382 Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, Stift J, Wrba F, Trauner M, Peck-Radosavljevic M, Reiberger T. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int. 2015;35:381-390. [PMID: 24953516 DOI: 10.1111/liv.12623] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 10.5] [Reference Citation Analysis]
383 Youssef AA, Issa HA, Omar MZ, Behiry EG, Elfallah AA, Hasaneen A, Darwish M, Ibrahim DB. Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality. Clin Exp Gastroenterol 2018;11:431-8. [PMID: 30538523 DOI: 10.2147/CEG.S171339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
384 Marcellin P, Estrabaud E. Recent advances in hepatology. Liver Int 2017;37:3-6. [DOI: 10.1111/liv.13323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
385 Liu CL, Soong RS, Lee WC, Jiang GW, Lin YC. Predicting Short-term Survival after Liver Transplantation using Machine Learning. Sci Rep. 2020;10:5654. [PMID: 32221367 DOI: 10.1038/s41598-020-62387-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
386 McPhail MJ, Shawcross DL, Abeles RD, Chang A, Patel V, Lee GH, Abdulla M, Sizer E, Willars C, Auzinger G. Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System. Clin Gastroenterol Hepatol. 2015;13:1353-1360.e8. [PMID: 25240417 DOI: 10.1016/j.cgh.2014.08.041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
387 Umbro I, Rossi M, Tinti F, Fiacco F, Piselli P, Ianni S, Ginanni Corradini S, Poli L, Berloco P, Mitterhofer A. Stages of Early Acute Renal Dysfunction in Liver Transplantation: The Influence of Graft Function. Transplantation Proceedings 2012;44:1953-5. [DOI: 10.1016/j.transproceed.2012.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
388 Wu D, Sun Z, Liu X, Rao Q, Chen W, Wang J, Xie Z, Zhang S, Jiang Z, Chen E, Huang K, Hu C, Zhang X, Wu J, Zhang Y, Gao H, Li L. HINT: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Aliment Pharmacol Ther 2018;48:750-60. [PMID: 30069888 DOI: 10.1111/apt.14927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
389 Deng H, Qi X, Peng Y, Li J, Li H, Zhang Y, Liu X, Sun X, Guo X. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit 2015;21:3961-77. [PMID: 26687574 DOI: 10.12659/msm.895005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
390 Elzouki AN, Hamad A, Almasri H, Ata M, Ashour A, Othman M, Badi A, Errayes M, Zahid M, Danjuma M. Predictors of Short-Term Mortality Following First Episode of Spontaneous Bacterial Peritonitis in Hospitalized Cirrhotic Patients. Cureus 2021;13:e18999. [PMID: 34853741 DOI: 10.7759/cureus.18999] [Reference Citation Analysis]
391 Bruns H, Hillebrand N, Schneider T, Hinz U, Fischer L, Schmidt J, Goldschmidt AJ, Schemmer P. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 2011;25:E558-65. [PMID: 21585550 DOI: 10.1111/j.1399-0012.2011.01483.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
392 Kumar D, Pandey G, Bansal D, Rawat A, Kumar U, Dubey D, Guleria A, Saraswat VA. NMR-based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients: Altered intestinal permeability in ACLF patients assessed by 1 H NMR. Magn Reson Chem 2017;55:289-96. [DOI: 10.1002/mrc.4525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
393 Huang B, Liu J, Li J, Schroder PM, Chen M, Deng R, Deng S. Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation. J Am Pharm Assoc (2003) 2019; 59: 816-823. e2. [PMID: 31521585 DOI: 10.1016/j.japh.2019.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
394 Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol 2009;44:346-57. [PMID: 18991165 DOI: 10.1080/00365520802530838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
395 Moussaoui D, Toso C, Nowacka A, McLin VA, Bednarkiewicz M, Andres A, Berney T, Majno P, Wildhaber BE. Early complications after liver transplantation in children and adults: Are split grafts equal to each other and equal to whole livers? Pediatr Transplant. 2017;21. [PMID: 28261944 DOI: 10.1111/petr.12908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
396 Wong F, Boyer TD, Sanyal AJ, Pappas SC, Escalante S, Jamil K. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome. Nephrol Dial Transplant. 2020;35:1554-1561. [PMID: 30887050 DOI: 10.1093/ndt/gfz048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
397 Kim JD, Choi JY, Park C, Song MJ, Jang JW, Bae SH, Yoon SK, Lee YS, You YK, Kim DG. Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes. Korean J Hepatol 2010;16:19. [DOI: 10.3350/kjhep.2010.16.1.19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
398 Mitterhofer AP, Tinti F, Umbro I, Pietropaolo V, Fiacco F, Bellizzi A, Anzivino E, Ginanni Corradini S, Poli L, Rossi M. Polyomavirus BK infection before liver transplantation in patients with chronic kidney disease. Transplant Proc. 2012;44:1934-1937. [PMID: 22974876 DOI: 10.1016/j.transproceed.2012.06.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
399 Pan JJ, Chen C, Geller B, Firpi R, Machicao VI, Caridi JG, Nelson DR, Morelli G. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents. Clin Radiol. 2008;63:1142-1148. [PMID: 18774362 DOI: 10.1016/j.crad.2008.04.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
400 Yue-Meng W, Li YH, Wu HM, Yang J, Xu Y, Yang LH, Yang JH. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis. Clin Exp Med 2017;17:233-41. [PMID: 27094312 DOI: 10.1007/s10238-016-0420-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
401 Bekelman JE, Asch DA, Tochner Z, Friedberg J, Vaughn DJ, Rash E, Raksowski K, Hahn SM. Principles and reality of proton therapy treatment allocation. Int J Radiat Oncol Biol Phys 2014;89:499-508. [PMID: 24798985 DOI: 10.1016/j.ijrobp.2014.03.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
402 Ho CM, Lee PH, Cheng WT, Hu RH, Wu YM, Ho MC. Succinct guide to liver transplantation for medical students. Ann Med Surg (Lond) 2016;12:47-53. [PMID: 27895907 DOI: 10.1016/j.amsu.2016.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
403 Chen T, Yang Z, Choudhury AK, Al Mahtab M, Li J, Chen Y, Tan SS, Han T, Hu J, Hamid SS, Huei LG, Ghazinian H, Nan Y, Chawla YK, Yuen MF, Devarbhavi H, Shukla A, Abbas Z, Sahu M, Dokmeci AK, Lesmana LA, Lesmana CRA, Xin S, Duan Z, Guo W, Ma K, Zhang Z, Cheng Q, Jia J, Sharma BC, Sarin SK, Ning Q. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019;13:695-705. [PMID: 31650510 DOI: 10.1007/s12072-019-09992-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
404 Ramachandran TM, Rajneesh AHR, Zacharia GS, Adarsh RP. Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo? J Clin Diagn Res 2017;11:OC01-5. [PMID: 29207749 DOI: 10.7860/JCDR/2017/30705.10529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
405 Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, Schreyer AG, Stroszczynski C, Wiggermann P. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 2014;4:5621. [PMID: 25001391 DOI: 10.1038/srep05621] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
406 Ghoshal UC, Das A. Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review. Hepatol Int 2008;2:31-8. [PMID: 19669277 DOI: 10.1007/s12072-007-9026-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
407 Liu N, Feng J, Lv Y, Liu Q, Deng J, Xia Y, Guo C, Zhou Y. Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study. Exp Ther Med 2019;18:4058-66. [PMID: 31611941 DOI: 10.3892/etm.2019.8011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
408 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
409 Hough CL, Caldwell ES, Cox CE, Douglas IS, Kahn JM, White DB, Seeley EJ, Bangdiwala SI, Rubenfeld GD, Angus DC, Carson SS; ProVent Investigators and the National Heart Lung and Blood Institute’s Acute Respiratory Distress Syndrome Network. Development and Validation of a Mortality Prediction Model for Patients Receiving 14 Days of Mechanical Ventilation. Crit Care Med 2015;43:2339-45. [PMID: 26247337 DOI: 10.1097/CCM.0000000000001205] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
410 Khalili H, Dayyeh BA, Friedman LS. Assessment of Liver Function in Clinical Practice. In: Ginès P, Kamath PS, Arroyo V, editors. Chronic Liver Failure. Totowa: Humana Press; 2011. pp. 47-76. [DOI: 10.1007/978-1-60761-866-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
411 Tapper EB, Catana AM, Sethi N, Mansuri D, Sethi S, Vong A, Afdhal NH. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis. Cancer 2016;122:852-8. [PMID: 26716758 DOI: 10.1002/cncr.29855] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
412 Gala KS, Vatsalya V. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 2020;9:E524. [PMID: 32106390 DOI: 10.3390/cells9030524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
413 García-compeán D, Jáquez-quintana JO, Lavalle-gonzález FJ, Reyes-cabello E, González-gonzález JA, Muñoz-espinosa LE, Vázquez-elizondo G, Villarreal-pérez JZ, Maldonado-garza HJ. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Annals of Hepatology 2012;11:240-8. [DOI: 10.1016/s1665-2681(19)31030-0] [Cited by in Crossref: 33] [Article Influence: 3.3] [Reference Citation Analysis]
414 Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV, Christodoulou D, Baltayiannis G. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. J Hepatol 2016;65:921-8. [PMID: 27297911 DOI: 10.1016/j.jhep.2016.06.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
415 Wang L, Xie L, Zhang N, Zhu W, Zhou J, Pan Q, Mao A, Lin Z, Wang L, Zhao Y. Predictive Value of Intraoperative Indocyanine Green Clearance Measurement on Postoperative Liver Function After Anatomic Major Liver Resection. J Gastrointest Surg 2020;24:1342-51. [PMID: 31197694 DOI: 10.1007/s11605-019-04262-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
416 Costa BP, Castro Sousa F, Serôdio M, Carvalho C. Value of MELD and MELD-Based Indices in Surgical Risk Evaluation of Cirrhotic Patients: Retrospective Analysis of 190 Cases. World J Surg 2009;33:1711-9. [DOI: 10.1007/s00268-009-0093-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
417 Pérez-ortiz M, Cruz-ramírez M, Ayllón-terán M, Heaton N, Ciria R, Hervás-martínez C. An organ allocation system for liver transplantation based on ordinal regression. Applied Soft Computing 2014;14:88-98. [DOI: 10.1016/j.asoc.2013.07.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
418 Mukherjee S, Sorrell MF. Controversies in liver transplantation for hepatitis C. Gastroenterology. 2008;134:1777-1788. [PMID: 18471554 DOI: 10.1053/j.gastro.2008.02.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
419 Saracino RM, Jutagir DR, Cunningham A, Foran-Tuller KA, Driscoll MA, Sledge WH, Emre SH, Fehon DC. Psychiatric Comorbidity, Health-Related Quality of Life, and Mental Health Service Utilization Among Patients Awaiting Liver Transplant. J Pain Symptom Manage 2018;56:44-52. [PMID: 29526612 DOI: 10.1016/j.jpainsymman.2018.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
420 Bajaj JS, Kakiyama G, Zhao D, Takei H, Fagan A, Hylemon P, Zhou H, Pandak WM, Nittono H, Fiehn O, Salzman N, Holtz M, Simpson P, Gavis EA, Heuman DM, Liu R, Kang DJ, Sikaroodi M, Gillevet PM. Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis. Alcohol Clin Exp Res 2017;41:1857-65. [DOI: 10.1111/acer.13498] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
421 Xun YH, Shi JP, Li CQ, Li D, Shi WZ, Pan QC, Guo JC, Zang GQ. Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure. Mol Med Rep 2014;9:1559-68. [PMID: 24573151 DOI: 10.3892/mmr.2014.1983] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
422 Everett BT, Lidofsky SD. Adherence to surveillance endoscopy following hospitalization for index esophageal variceal hemorrhage. World J Gastrointest Surg 2018; 10(4): 40-48 [PMID: 29707105 DOI: 10.4240/wjgs.v10.i4.40] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
423 Bahra M, Neuhaus P. Liver transplantation in the high MELD era: a fair chance for everyone? Langenbecks Arch Surg. 2011;396:461-465. [PMID: 21384189 DOI: 10.1007/s00423-011-0766-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
424 Lim YS. [Prediction of post-operative mortality in patients with cirrhosis: growth of child to MELD]. Korean J Gastroenterol 2011;57:333-4. [PMID: 21694483 DOI: 10.4166/kjg.2011.57.6.333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
425 Piñero F, Marciano S, Villamil A, Bandi J, Casciato P, Galdame O, Giannasi S, de Santibañes E, Gadano A. Sicker Patients for Liver Transplantation: Meld, Meld Sodium, and Integrated Meld’s Prognostic Accuracy in the Assessment of Posttransplantation Events at a Single Center from Argentina. ISRN Transplantation 2013;2013:1-7. [DOI: 10.5402/2013/102590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
426 Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007;46:1138-1145. [PMID: 17668882 DOI: 10.1002/hep.21787] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 6.6] [Reference Citation Analysis]
427 Rajakumar A, Appuswamy E, Kaliamoorthy I, Rela M. Renal Dysfunction in Cirrhosis: Critical Care Management. Indian J Crit Care Med 2021;25:207-14. [PMID: 33707901 DOI: 10.5005/jp-journals-10071-23721] [Reference Citation Analysis]
428 Tong JJ, Zhao W, Mu XY, Xu X, Su HB, Liu XY, Chen J, Zhai XR, Wang Y, Hu JH. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl) 2019;132:1541-9. [PMID: 31188162 DOI: 10.1097/CM9.0000000000000298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
429 Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid Drugs in Patients With Liver Disease: A Systematic Review. Hepat Mon 2016;16:e32636. [PMID: 27257423 DOI: 10.5812/hepatmon.32636] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
430 Yarema MC, Johnson DW, Sivilotti MLA, Nettel-Aguirre A, DeWitt C, Gosselin S, Murphy N, Victorino C, Bailey B, Dong K, Haney E, Purssell R, Thompson M, Lord JA, Spyker DA, Rumack BH. Predicting mortality from acetaminophen poisoning shortly after hospital presentation. Br J Clin Pharmacol 2021;87:3332-43. [PMID: 33507553 DOI: 10.1111/bcp.14755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
431 Rashidi-Alavijeh J, Ceylan AS, Wedemeyer H, Kleefisch M, Willuweit K, Lange CM. Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis. PLoS One 2020;15:e0236528. [PMID: 32722691 DOI: 10.1371/journal.pone.0236528] [Reference Citation Analysis]
432 Bucsics T, Schoder M, Diermayr M, Feldner-Busztin M, Goeschl N, Bauer D, Schwabl P, Mandorfer M, Angermayr B, Cejna M, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Karner J, Karnel F, Reiberger T. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience. PLoS One 2018;13:e0189414. [PMID: 29315304 DOI: 10.1371/journal.pone.0189414] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
433 Shao L, Han B, An S, Ma J, Guo X, Romeiro FG, Mancuso A, Qi X. Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis. Transl Gastroenterol Hepatol 2017;2:88. [PMID: 29264426 DOI: 10.21037/tgh.2017.09.11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
434 Haimerl M, Verloh N, Zeman F, Fellner C, Nickel D, Lang SA, Teufel A, Stroszczynski C, Wiggeramann P. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry. Sci Rep. 2017;7:43347. [PMID: 28266528 DOI: 10.1038/srep43347] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
435 Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen J, Mullis D, Kwo P, Chalasani N. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 2011;9:254-9. [PMID: 21092762 DOI: 10.1016/j.cgh.2010.10.035] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 9.4] [Reference Citation Analysis]
436 Ilan Y. A fourth dimension in decision making in hepatology. Hepatol Res 2010;40:1143-54. [PMID: 20973886 DOI: 10.1111/j.1872-034X.2010.00737.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
437 Kang H, Park J, Lee JJ, Kim GS. Hyperthermia associated with biliary obstruction during living donor liver transplantation. Korean J Anesthesiol 2018;71:323-7. [PMID: 29690758 DOI: 10.4097/kja.d.18.27211] [Reference Citation Analysis]
438 Yoshikawa K, Iwasa M, Eguchi A, Kojima S, Yoshizawa N, Tempaku M, Sugimoto R, Yamamoto N, Sugimoto K, Kobayashi Y, Hasegawa H, Takei Y. Neutrophil gelatinase-associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases. Hepatol Commun 2017;1:946-56. [PMID: 29404502 DOI: 10.1002/hep4.1109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
439 Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15:685-698. [PMID: 22032523 DOI: 10.1016/j.cld.2011.08.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
440 Gungor G, Ataseven H, Demir A, Solak Y, Gaipov A, Biyik M, Ozturk B, Polat I, Kiyici A, Cakir OO. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study. Liver Int. 2014;34:49-57. [PMID: 23799980 DOI: 10.1111/liv.12232] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
441 Bennink RJ, Tulchinsky M, de Graaf W, Kadry Z, van Gulik TM. Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 2012;42:124-37. [PMID: 22293167 DOI: 10.1053/j.semnuclmed.2011.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
442 Berardis S, Sattwika PD, Najimi M, Sokal EM. Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World J Gastroenterol 2015; 21(3): 742-758 [PMID: 25624709 DOI: 10.3748/wjg.v21.i3.742] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 71] [Article Influence: 10.6] [Reference Citation Analysis]
443 Mishra A, Rustgi V. Prognostic Models in Acute Liver Failure. Clin Liver Dis. 2018;22:375-388. [PMID: 29605072 DOI: 10.1016/j.cld.2018.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
444 Kasztelan-Szczerbińska B, Surdacka A, Celiński K, Roliński J, Zwolak A, Miącz S, Szczerbiński M. Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences. PLoS One 2015;10:e0128347. [PMID: 26107937 DOI: 10.1371/journal.pone.0128347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
445 Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13:473-485. [PMID: 27353402 DOI: 10.1038/nrgastro.2016.97] [Cited by in Crossref: 152] [Cited by in F6Publishing: 138] [Article Influence: 25.3] [Reference Citation Analysis]
446 Yao J, Feng XW, Yu XB, Xie HY, Zhu LX, Yang Z, Wei BJ, Zheng SS, Zhou L. Recipient IL-6-572C/G genotype is associated with reduced incidence of acute rejection following liver transplantation. J Int Med Res 2013;41:356-64. [PMID: 23569034 DOI: 10.1177/0300060513477264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
447 Brennan IM, Faintuch S, Ahmed M. Preparation for Percutaneous Ablation Procedures. Techniques in Vascular and Interventional Radiology 2013;16:209-18. [DOI: 10.1053/j.tvir.2013.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
448 Albertsen A. Drinking in the last chance saloon: luck egalitarianism, alcohol consumption, and the organ transplant waiting list. Med Health Care and Philos 2016;19:325-38. [DOI: 10.1007/s11019-016-9684-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
449 Lünse S, Heidecke C, Partecke LI; Department of General Surgery, Visceral, Thoracic and Vascular Surgery, Universitätsmedizin Greifswald, Greifswald, Germany, Department of General Surgery, Visceral, Thoracic and Vascular Surgery, Universitätsmedizin Greifswald, Greifswald, Germany, Department of General, Visceral and Thoracic Surgery, Helios Klinikum Schleswig, Schleswig, Germany. Current Topics and Perspectives in Surgical Management of Hepatocellular Carcinoma. In: Tirnitz-parker JE, editor. Hepatocellular Carcinoma. Codon Publications; 2019. pp. 111-25. [DOI: 10.15586/hepatocellularcarcinoma.2019.ch6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
450 Peng Y, Wei Q, Liu Y, Wu Z, Zhang H, Wu H, Chai J. Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterol Res Pract 2021;2021:5623601. [PMID: 34712321 DOI: 10.1155/2021/5623601] [Reference Citation Analysis]
451 Kumral D, Caldwell SH, Argo CK. Impact of an Institutional Change in Prothrombin Time Methodology on INR and MELD Scores in Liver Transplant Evaluations. J Clin Lab Anal 2016;30:968-71. [PMID: 27076282 DOI: 10.1002/jcla.21964] [Reference Citation Analysis]
452 Seki A, Sakai Y, Komura T, Nasti A, Yoshida K, Higashimoto M, Honda M, Usui S, Takamura M, Takamura T, Ochiya T, Furuichi K, Wada T, Kaneko S. Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. Hepatology 2013;58:1133-42. [PMID: 23686813 DOI: 10.1002/hep.26470] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
453 Kim JD, Choi JY, Bae SH, Yoon SK, Yang JM, Han NI, Choi SW, Lee CD, Lee YS, Jung ES. Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis. Clinical Gastroenterology and Hepatology 2010;8:60-5. [DOI: 10.1016/j.cgh.2009.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
454 Ow MMG, Erasmus P, Minto G, Struthers R, Joseph M, Smith A, Warshow UM, Cramp ME, Cross TJS. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation: Functional Capacity Predicts Short-Term Mortality. Liver Transpl 2014;20:1081-8. [DOI: 10.1002/lt.23907] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
455 Mahassadi AK, Nguieguia JLK, Kissi HY, Awuah AA, Bangoura AD, Doffou SA, Attia AK. Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study. Clin Exp Gastroenterol 2018;11:143-52. [PMID: 29670387 DOI: 10.2147/CEG.S140655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
456 Stickel F, Inderbitzin D, Candinas D. Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr Rev. 2008;66:47-54. [PMID: 18254884 DOI: 10.1111/j.1753-4887.2007.00005.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
457 Syha R, Ketelsen D, Heller S, Schmehl J, Mangold S, Heuschmid M, Springer F, Claussen CD, Brechtel K. Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST. Eur J Gastroenterol Hepatol 2012;24:1325-32. [PMID: 22872074 DOI: 10.1097/MEG.0b013e32835724bc] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
458 Akamatsu N, Sugawara Y, Kanako J, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Low Platelet Counts and Prolonged Prothrombin Time Early After Operation Predict the 90 Days Morbidity and Mortality in Living-donor Liver Transplantation. Ann Surg 2017;265:166-72. [PMID: 28009742 DOI: 10.1097/SLA.0000000000001634] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
459 Gagliotti C, Morsillo F, Moro ML, Masiero L, Procaccio F, Vespasiano F, Pantosti A, Monaco M, Errico G, Ricci A, Grossi P, Nanni Costa A; SInT Collaborative Study Group. Infections in liver and lung transplant recipients: a national prospective cohort. Eur J Clin Microbiol Infect Dis 2018;37:399-407. [PMID: 29380226 DOI: 10.1007/s10096-018-3183-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
460 Li J, Han B, Li H, Deng H, Méndez-Sánchez N, Guo X, Qi X. Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis. Saudi J Gastroenterol 2018;24:220-7. [PMID: 29956689 DOI: 10.4103/sjg.SJG_486_17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
461 Zhou XD, Chen QF, Zhang MC, Van Poucke S, Liu WY, Lu Y, Shi KQ, Huang WJ, Zheng MH. Scoring model to predict outcome in critically ill cirrhotic patients with acute respiratory failure: comparison with MELD scoring models and CLIF-SOFA score. Expert Rev Gastroenterol Hepatol 2017;11:857-64. [PMID: 28597703 DOI: 10.1080/17474124.2017.1338948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
462 Karp SJ. The Importance of Outcome Metrics in Allocation Policy. Transplantation 2018;102:1968-9. [PMID: 29944620 DOI: 10.1097/TP.0000000000002342] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
463 Wieser V, Tymoszuk P, Adolph TE, Grander C, Grabherr F, Enrich B, Pfister A, Lichtmanegger L, Gerner R, Drach M. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease. J Hepatol. 2016;64:872-880. [PMID: 26682726 DOI: 10.1016/j.jhep.2015.11.037] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
464 Beckebaum S, Sotiropoulos GC, Gerken G, Cicinnati VR. Hepatitis B and liver transplantation: 2008 update. Rev Med Virol 2009;19:7-29. [DOI: 10.1002/rmv.595] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
465 Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Smolen A, Szczerbinski M. Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflamm. 2013;2013:148526. [PMID: 24259947 DOI: 10.1155/2013/148526] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
466 Lee S, Choi D, Jeong WK. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis. J Magn Reson Imaging. 2016;44:1339-1345. [PMID: 27197633 DOI: 10.1002/jmri.25288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
467 Okano T, Motoki H, Minamisawa M, Kimura K, Kanai M, Yoshie K, Higuchi S, Saigusa T, Ebisawa S, Okada A, Shoda M, Kuwahara K. Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure. PLoS One 2020;15:e0241003. [PMID: 33095810 DOI: 10.1371/journal.pone.0241003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
468 Jara M, Bednarsch J, Malinowski M, Lüttgert K, Orr J, Puhl G, Seehofer D, Neuhaus P, Stockmann M. Predictors of quality of life in patients evaluated for liver transplantation. Clin Transplant 2014;28:1331-8. [PMID: 25053350 DOI: 10.1111/ctr.12426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
469 Zhang Y, Long X, Ruan X, Wei Q, Zhang L, Wo L, Huang D, Lin L, Wang D, Xia L, Zhao Q, Liu J, Zhao Q, He M. SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury. Cell Discov 2021;7:93. [PMID: 34642310 DOI: 10.1038/s41421-021-00326-6] [Reference Citation Analysis]
470 Locklear CT, Golabi P, Gerber L, Younossi ZM. Exercise as an intervention for patients with end-stage liver disease: Systematic review. Medicine (Baltimore). 2018;97:e12774. [PMID: 30334965 DOI: 10.1097/md.0000000000012774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
471 Ferrarese A, Sartori G, Orrù G, Frigo AC, Pelizzaro F, Burra P, Senzolo M. Machine learning in liver transplantation: a tool for some unsolved questions? Transpl Int 2021;34:398-411. [PMID: 33428298 DOI: 10.1111/tri.13818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
472 Downs EA, Ailawadi G. Invited Commentary on Grimm et al. MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation. Ann Thorac Surg 2015;100:1737-43. Ann Thorac Surg 2016;101:e61. [PMID: 26777975 DOI: 10.1016/j.athoracsur.2015.08.009] [Reference Citation Analysis]
473 Littera R, Zamboni F, Tondolo V, Fantola G, Chessa L, Orrù N, Sanna M, Valentini D, Cappai L, Mulargia M, Caocci G, Arras M, Floris A, Orrù S, La Nasa G, Carcassi C. Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma. Hum Immunol 2013;74:1288-94. [PMID: 23756163 DOI: 10.1016/j.humimm.2013.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
474 Feyssa E, Ortiz J, Grewal K, Azhar A, Parsikia A, Tufail K, Hashemi N, Brady P, Araya V. MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. Transplantation. 2011;91:786-792. [PMID: 21304440 DOI: 10.1097/tp.0b013e31820e014e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
475 Sharma AM, Khairnar R, Kowalski ES, Remick J, Nichols EM, Mohindra P, Yock T, Regine W, Mishra MV. Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation. Cureus 2019;11:e5703. [PMID: 31720171 DOI: 10.7759/cureus.5703] [Reference Citation Analysis]
476 Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT. Strategies for prediction and mitigation of radiation-induced liver toxicity. J Radiat Res 2018;59:i40-9. [PMID: 29432550 DOI: 10.1093/jrr/rrx104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
477 Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list. Liver Int 2014;34:1176-83. [PMID: 24256642 DOI: 10.1111/liv.12373] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
478 Jundt MC, Owen RL, Thompson SM, Fleming CJ, Stockland AH, Andrews JC. MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization. Abdom Radiol (NY) 2021. [PMID: 34633495 DOI: 10.1007/s00261-021-03306-2] [Reference Citation Analysis]
479 Yohanathan L, Heimbach JK. The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma. Clinics in Liver Disease 2020;24:657-63. [DOI: 10.1016/j.cld.2020.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
480 Piechota M, Piechota A. An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepat Mon. 2016;16:e34127. [PMID: 27642344 DOI: 10.5812/hepatmon.34127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
481 Biselli M, Gramenzi A, Lenzi B, Dall'Agata M, Pierro ML, Perricone G, Tonon M, Bellettato L, D'Amico G, Angeli P, Boffelli S, Bonavita ME, Domenicali M, Caraceni P, Bernardi M, Trevisani F. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding. Clin Gastroenterol Hepatol 2019;17:1388-1397.e1. [PMID: 30557740 DOI: 10.1016/j.cgh.2018.12.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
482 Martinez-Mier G, Esquivel-Torres S, Medina Granados JP, Luna-Castillo M, Castillo-Chiquete R, Calzada-Grijalva JF, Gonzalez-Velazquez F. [Presentation, staging, and outcome of patients with hepatocellular carcinoma at a center in Veracruz, Mexico]. Rev Gastroenterol Mex 2014;79:171-9. [PMID: 25236795 DOI: 10.1016/j.rgmx.2014.05.007] [Reference Citation Analysis]
483 Lee J, Chung MY. Does the model for end-stage liver disease score predict transfusion amount, acid-base imbalance, haemodynamic and oxidative abnormalities during living donor liver transplantation? J Int Med Res 2011;39:1773-82. [PMID: 22117978 DOI: 10.1177/147323001103900520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
484 Umbro I, Tinti F, Fiacco F, Zavatto A, Piselli P, Di Natale V, Lai S, Vitarelli A, Corradini SG, Rossi M. Resistive index and MELD-Na: nephrologic monitoring in cirrhotic patients awaiting liver transplantation. Transplant Proc. 2013;45:2676-2679. [PMID: 24034022 DOI: 10.1016/j.transproceed.2013.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
485 Lee HS, Choi GH, Joo DJ, Kim MS, Kim SI, Han KH, Ahn SH, Kim DY, Park JY, Choi JS. Prognostic value of model for end-stage liver disease scores in patients with fulminant hepatic failure. Transplant Proc. 2013;45:2992-2994. [PMID: 24157020 DOI: 10.1016/j.transproceed.2013.08.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
486 King LY, Canasto-Chibuque C, Johnson KB, Yip S, Chen X, Kojima K, Deshmukh M, Venkatesh A, Tan PS, Sun X. A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. Gut. 2015;64:1296-1302. [PMID: 25143343 DOI: 10.1136/gutjnl-2014-307862] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
487 Aranzana EM, Coppini AZ, Ribeiro MA, Massarollo PC, Szutan LA, Ferreira FG. Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo) 2015;70:413-8. [PMID: 26106959 DOI: 10.6061/clinics/2015(06)05] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
488 Zhao J, Li S, Ren L, Guo X, Qi X. Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis. Am J Med Sci 2017;354:131-9. [PMID: 28864370 DOI: 10.1016/j.amjms.2017.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
489 Besa C, Bane O, Jajamovich G, Marchione J, Taouli B. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magnetic Resonance Imaging 2015;33:1075-82. [DOI: 10.1016/j.mri.2015.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
490 Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294 [PMID: 28839428 DOI: 10.3748/wjg.v23.i29.5282] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 113] [Article Influence: 23.6] [Reference Citation Analysis]
491 Stącel T, Nęcki M, Latos M, Urlik M, Antończyk R, Kos A, Zawadzki F, Wajda-Pokrontka M, Przybyłowski P, Zembala M, Ochman M. Model for End-Stage Liver Disease (MELD) Score Among Patients Qualified For Lung Transplantation With End-Stage Lung Diseases With Particular Consideration of Median Pulmonary Artery Pressure. Transplant Proc 2020;52:2128-32. [PMID: 32553508 DOI: 10.1016/j.transproceed.2020.03.043] [Reference Citation Analysis]
492 Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54:1297-1306. [PMID: 21145851 DOI: 10.1016/j.jhep.2010.11.008] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
493 Verloh N, Utpatel K, Zeman F, Fellner C, Schlitt HJ, Müller M, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences. Oncotarget 2018;9:36371-8. [PMID: 30555635 DOI: 10.18632/oncotarget.26368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
494 Zhao J, Qi X, Hou F, Ning Z, Zhang X, Deng H, Peng Y, Li J, Wang X, Li H. Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis. Am J Med Sci. 2016;352:285-295. [PMID: 27650234 DOI: 10.1016/j.amjms.2016.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
495 Ravaioli M, Grazi GL, Cescon M, Cucchetti A, Ercolani G, Fiorentino M, Panzini I, Vivarelli M, Ramacciato G, Del Gaudio M. Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int. 2009;22:423-433. [PMID: 19040483 DOI: 10.1111/j.1432-2277.2008.00812.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
496 Kukuk GM, Schaefer SG, Fimmers R, Hadizadeh DR, Ezziddin S, Spengler U, Schild HH, Willinek WA. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests. Eur Radiol. 2014;24:2482-2490. [PMID: 25030459 DOI: 10.1007/s00330-014-3291-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
497 Xiao X, Gang Y, Gu Y, Zhao L, Chu J, Zhou J, Cai X, Zhang H, Xu L, Nie Y. Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation. Dig Dis Sci. 2012;57:2883-2891. [PMID: 22661273 DOI: 10.1007/s10620-012-2248-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
498 Bajaj JS. The role of microbiota in hepatic encephalopathy. Gut Microbes. 2014;5:397-403. [PMID: 24690956 DOI: 10.4161/gmic.28684] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 10.8] [Reference Citation Analysis]
499 Kimmann M, Tergast TL, Schultalbers M, Laser H, Gerbel S, Manns MP, Cornberg M, Maasoumy B. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis. PLoS One 2019;14:e0220666. [PMID: 31374111 DOI: 10.1371/journal.pone.0220666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
500 Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011;140:1952-1960. [PMID: 21334338 DOI: 10.1053/j.gastro.2011.02.017] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
501 Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML. Wilson disease. Nat Rev Dis Primers 2018;4:21. [PMID: 30190489 DOI: 10.1038/s41572-018-0018-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 33.5] [Reference Citation Analysis]
502 Virlogeux V, Pradat P, Bailly F, Funingana G, Gonçalves F, Maynard M, Hartig-Lavie K, Amiri M, Zoulim F. Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score. J Viral Hepat. 2014;21:e98-e107. [PMID: 24612466 DOI: 10.1111/jvh.12237] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
503 Fabes J, Ambler G, Shah B, Williams NR, Martin D, Davidson BR, Spiro M. Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation. BMJ Open 2021;11:e055864. [PMID: 34857585 DOI: 10.1136/bmjopen-2021-055864] [Reference Citation Analysis]
504 Suk KT, Kim MY, Jeong SW, Jang JY, Jang YO, Baik SK. Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study. Dig Dis Sci 2018;63:248-56. [DOI: 10.1007/s10620-017-4868-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
505 Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDS 2012;26:73-80. [PMID: 22239101 DOI: 10.1089/apc.2011.0191] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
506 Shin HS, Kim SP, Han SH, Kim DY, Ahn SH, Han KH, Chon CY, Park JY. Prognostic indicators for acute liver failure development and mortality in patients with hepatitis A: consecutive case analysis. Yonsei Med J 2014;55:953-9. [PMID: 24954323 DOI: 10.3349/ymj.2014.55.4.953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
507 Weismüller TJ, Negm A, Becker T, Barg-hock H, Klempnauer J, Manns MP, Strassburg CP. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transplant International 2009;22:970-8. [DOI: 10.1111/j.1432-2277.2009.00915.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
508 Cai Q, Zhu M, Duan J, Wang H, Sheng J. Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis. J Int Med Res 2019;47:4492-504. [PMID: 31364441 DOI: 10.1177/0300060519862065] [Reference Citation Analysis]
509 Amjad W, Alukal J, Doycheva I, Zhang T, Maheshwari A, Yoo H, Thuluvath PJ. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis. Dig Dis Sci 2020;65:3726-33. [DOI: 10.1007/s10620-020-06142-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
510 Kumar U, Sharma S, Durgappa M, Gupta N, Raj R, Kumar A, Sharma PN, Krishna VP, Kumar RV, Guleria A, Saraswat VA, Pande G, Kumar D. Serum Metabolic Disturbances Associated with Acute-on-chronic Liver Failure in Patients with Underlying Alcoholic Liver Diseases: An Elaborative NMR-based Metabolomics Study. J Pharm Bioallied Sci 2021;13:276-82. [PMID: 34349490 DOI: 10.4103/JPBS.JPBS_333_20] [Reference Citation Analysis]
511 Kaiser T, Kinny-Köster B, Gnewuch C, Karailieva D, Kiehntopf M, Kessler A, Ritter-Sket C, Schmidt M, Brand K, Thiery J, Lichtinghagen R. Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score. Pract Lab Med 2017;8:41-8. [PMID: 28856226 DOI: 10.1016/j.plabm.2017.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
512 Strassburg CP, Manns MP. [Liver transplantation: indications and results]. Internist (Berl). 2009;50:550-560. [PMID: 19387600 DOI: 10.1007/s00108-008-2268-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
513 Lei Z, Mo Z, Zhu J, Pang X, Zheng X, Wu Z, Wang K, Li X, Xie D, Gao Z. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure. Mediators Inflamm 2015;2015:535938. [PMID: 25892854 DOI: 10.1155/2015/535938] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
514 Prié D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M, Eladari D, Lebrec D, Durand F, Friedlander G. Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. PLoS One 2013;8:e66182. [PMID: 23825530 DOI: 10.1371/journal.pone.0066182] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
515 Boerr E, Anders M, Mella J, Quiñonez E, Goldaracena N, Orozco F, McCormack L, Mastai R. [Cost analysis of liver transplantation in a community hospital: association with the Model for End-stage Liver Disease, a prognostic index to prioritize the most severe patients]. Gastroenterol Hepatol 2013;36:1-6. [PMID: 23123035 DOI: 10.1016/j.gastrohep.2012.08.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
516 Nash E, Sabih AH, Chetwood J, Wood G, Pandya K, Yip T, Majumdar A, McCaughan GW, Strasser SI, Liu K. Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements. Med J Aust 2021;215:261-8. [PMID: 34272737 DOI: 10.5694/mja2.51173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
517 Mandorfer M, Kozbial K, Freissmuth C, Schwabl P, Stättermayer AF, Reiberger T, Beinhardt S, Schwarzer R, Trauner M, Ferlitsch A. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses. Aliment Pharmacol Ther. 2015;42:707-718. [PMID: 26179884 DOI: 10.1111/apt.13315] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
518 Lu CX, Chen HL, Shen WQ, Feng LP. A new nomogram score for predicting surgery-related pressure ulcers in cardiovascular surgical patients. Int Wound J 2017;14:226-32. [PMID: 26991609 DOI: 10.1111/iwj.12593] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
519 Legaz I, Boix F, López M, Alfaro R, Galián JA, Llorente S, Campillo JA, Botella C, Ramírez P, Sánchez-Bueno F, Pons JA, Moya-Quiles MR, Minguela A, Muro M. Influence of Preformed Antibodies in Liver Transplantation. J Clin Med 2020;9:E708. [PMID: 32151032 DOI: 10.3390/jcm9030708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
520 Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, Zhao YL, Zhang YF, He TT, Yu SM, Guo YM, Zhang F, Xiao XH, Schulze J. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019;30:47-58. [PMID: 30289391 DOI: 10.5152/tjg.2018.17847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
521 Briceño J, Ciria R, de la Mata M. Donor-recipient matching: Myths and realities. Journal of Hepatology 2013;58:811-20. [DOI: 10.1016/j.jhep.2012.10.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
522 Fan YC, Wang N, Sun YY, Xiao XY, Wang K. TIPE2 mRNA Level in PBMCs Serves as a Novel Biomarker for Predicting Short-Term Mortality of Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Single-Center Study. Medicine (Baltimore) 2015;94:e1638. [PMID: 26426653 DOI: 10.1097/MD.0000000000001638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
523 Tsuda K, Koide M, Kunii Y, Watanabe K, Miyairi S, Ohashi Y, Harada T. Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery. Interact Cardiovasc Thorac Surg 2013;16:630-5. [PMID: 23403770 DOI: 10.1093/icvts/ivt014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
524 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. 2017;7:340-357. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
525 Sezer S, Karakan S, Erişmiş B, Çolak T, Haberal M. Risk factors for kidney impairment and differential impact of liver transplantation on renal function. Transplant Proc 2011;43:609-11. [PMID: 21440776 DOI: 10.1016/j.transproceed.2011.01.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
526 Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, Charpignon C, Lédinghen Vd, Grenouillet-Delacre M, Habersetzer F, Nousbaum JB, Denninger MH, Valla DC, Plessier A. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140-1146. [PMID: 19337247 DOI: 10.1038/ajg.2009.63] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
527 Zhai XR, Tong JJ, Wang HM, Xu X, Mu XY, Chen J, Liu ZF, Wang Y, Su HB, Hu JH. Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:320. [PMID: 32993547 DOI: 10.1186/s12876-020-01473-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
528 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, da Silva OM, de Souza Menegassi V, Dos Santos CR, de Moraes ACR, de Lucca Schiavon L, Santos-Silva MC. Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients. Sci Rep 2021;11:5923. [PMID: 33723292 DOI: 10.1038/s41598-021-85148-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Thornton JG, Mullen KD. The role of hepatic encephalopathy in the era of MELD. Liver Transpl 2007;13:1364-5. [DOI: 10.1002/lt.21229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
530 Lee CH, Kim IH. Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis. Gut Liver 2021;15:490-1. [PMID: 34261817 DOI: 10.5009/gnl210296] [Reference Citation Analysis]
531 Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, Hamid S, Kim DJ, Komolmit P, Lata S, Lee GH, Lesmana LA, Mahtab M, Maiwall R, Moreau R, Ning Q, Pamecha V, Payawal DA, Rastogi A, Rahman S, Rela M, Saraya A, Samuel D, Saraswat V, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Butt AS, Tan SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O;  APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8:453-471. [PMID: 26202751 DOI: 10.1007/s12072-014-9580-2] [Cited by in Crossref: 354] [Cited by in F6Publishing: 306] [Article Influence: 44.3] [Reference Citation Analysis]
532 Schwier E, Kirchner C, Eickmeyer C, Winde G, Henzler D, Köhler T. Profound decrease of liver maximum function capacity test of isoflurane sedated patients: A report of three cases. Clin Case Rep 2021;9:e04862. [PMID: 34594555 DOI: 10.1002/ccr3.4862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 Gardiner C, Kohama K, Patel I, Lane P, Dwyer S, Machin SJ, Mackie IJ. A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem PT). Int J Lab Hem 2017;39:532-8. [DOI: 10.1111/ijlh.12691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
534 Ye J, Wu Y, Li M, Gong X, Zhong B. Keratin 8 Mutations Were Associated With Susceptibility to Chronic Hepatitis B and Related Progression. J Infect Dis 2020;221:464-73. [PMID: 31515557 DOI: 10.1093/infdis/jiz467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
535 Wang R, Qi X, Peng Y, Deng H, Li J, Ning Z, Dai J, Hou F, Zhao J, Guo X. Association of umbilical hernia with volume of ascites in liver cirrhosis: a retrospective observational study. J Evid Based Med 2016;9:170-80. [PMID: 27792277 DOI: 10.1111/jebm.12225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
536 Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, Shi D, Jiang J, Sun S, Jin L, Ye P, Yang L, Lu Y, Li T, Huang J, Xu X, Chen J, Hao S, Chen Y, Xin S, Gao Z, Duan Z, Han T, Wang Y, Gan J, Feng T, Pan C, Li H, Huang Y, Xie Q, Lin S, Li L;  Chinese Group on the Study of Severe Hepatitis B (COSSH). Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67:2181-2191. [PMID: 28928275 DOI: 10.1136/gutjnl-2017-314641] [Cited by in Crossref: 74] [Cited by in F6Publishing: 81] [Article Influence: 14.8] [Reference Citation Analysis]
537 AlDhaleei W, AlAhmad M, Alhosani I. Wilson's Disease Presenting in Late Adult Life. Case Rep Gastroenterol 2021;15:142-6. [PMID: 33708062 DOI: 10.1159/000512422] [Reference Citation Analysis]
538 Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Transplant Proc 2012;44:389-92. [PMID: 22410024 DOI: 10.1016/j.transproceed.2012.01.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
539 Durand F, Roux O, Weiss E, Francoz C. Acute-on-chronic liver failure: Where do we stand? Liver Int 2021;41 Suppl 1:128-36. [PMID: 34155793 DOI: 10.1111/liv.14855] [Reference Citation Analysis]
540 Xia VW, Taniguchi M, Steadman RH. The changing face of patients presenting for liver transplantation. Curr Opin Organ Transplant. 2008;13:280-284. [PMID: 18685318 DOI: 10.1097/mot.0b013e328300a070] [Cited by in Crossref: 60] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
541 Teng M, Pirrie S, Ward DG, Assi LK, Hughes RG, Stocken D, Johnson PJ. Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. Br J Cancer. 2014;110:2277-2282. [PMID: 24603305 DOI: 10.1038/bjc.2014.121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
542 Chen WT, Lin CY, Sheen IS, Huang CW, Lin TN, Lin CJ, Jeng WJ, Huang CH, Ho YP, Chiu CT. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol 2011; 17(16): 2120-2125 [PMID: 21547132 DOI: 10.3748/wjg.v17.i16.2120] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
543 Andres A, Montano-Loza A, Greiner R, Uhlich M, Jin P, Hoehn B, Bigam D, Shapiro JAM, Kneteman NM. A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis. PLoS One 2018;13:e0193523. [PMID: 29543895 DOI: 10.1371/journal.pone.0193523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
544 Runyon BA. A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm. Int J Hepatol. 2011;2011:801983. [PMID: 22121492 DOI: 10.4061/2011/801983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
545 Peeraphatdit T, Naksuk N, Thongprayoon C, Harmsen WS, Therneau TM, Ricci P, Roberts LR, Chaiteerakij R. Prognostic Value of Model for End-Stage Liver Disease Score Measurements on a Daily Basis in Critically Ill Patients With Cirrhosis. Mayo Clin Proc 2015;90:1196-206. [PMID: 26249009 DOI: 10.1016/j.mayocp.2015.06.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
546 Kim TY, Suk KT, Jeong SW, Ryu T, Kim DJ, Baik SK, Sohn JH, Jeong WK, Choi E, Jang JY, Kim MY. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients. J Korean Med Sci 2019;34:e223. [PMID: 31436052 DOI: 10.3346/jkms.2019.34.e223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
547 Solà E, Kerbert AJ, Verspaget HW, Moreira R, Pose E, Ruiz P, Cela R, Morales-Ruiz M, López E, Graupera I, Solé C, Huelin P, Navarro AA, Ariza X, Jalan R, Fabrellas N, Benten D, de Prada G, Durand F, Jimenez W, van der Reijden JJ, Fernandez J, van Hoek B, Coenraad MJ, Ginès P. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis. J Hepatol 2016;65:914-20. [PMID: 27422752 DOI: 10.1016/j.jhep.2016.07.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
548 Saxena V, Terrault NA. Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander? Dig Dis Sci 2015;60:806-9. [PMID: 25586091 DOI: 10.1007/s10620-015-3535-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
549 McGill MR, Staggs VS, Sharpe MR, Lee WM, Jaeschke H. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology. 2014;60:1336-1345. [PMID: 24923598 DOI: 10.1002/hep.27265] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 11.1] [Reference Citation Analysis]
550 Stone DJ, Csete M. Actuating critical care therapeutics. J Crit Care 2016;35:90-5. [PMID: 27481741 DOI: 10.1016/j.jcrc.2016.05.002] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
551 Xiong L, Du Y, Zhou T, Du B, Visalath P, Lin L, Bao S, Cai W. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus. J Gastroenterol Hepatol 2019;34:1800-8. [PMID: 30771232 DOI: 10.1111/jgh.14634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
552 Glavind E, Aagaard NK, Gronbaek H, Orntoft NW, Vilstrup H, Thomsen KL. Time course of compromised urea synthesis in patients with alcoholic hepatitis. Scand J Gastroenterol. 2018;53:592-597. [PMID: 29113530 DOI: 10.1080/00365521.2017.1399163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
553 Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B. Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One 2012;7:e45652. [PMID: 23029162 DOI: 10.1371/journal.pone.0045652] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
554 Paternostro R, Kapzan L, Mandorfer M, Schwarzer R, Benedikt S, Viveiros A, Bauer D, Ferlitsch M, Zoller H, Trauner M, Ferlitsch A. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes. J Gastroenterol Hepatol. 2020;35:1619-1627. [PMID: 31972057 DOI: 10.1111/jgh.14988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
555 Castro-Narro GE. [Liver transplantation]. Rev Gastroenterol Mex 2012;77 Suppl 1:94-6. [PMID: 22939497 DOI: 10.1016/j.rgmx.2012.07.036] [Reference Citation Analysis]
556 El Ray A, Fouad R, ElMakhzangy H, El Beshlawy M, Moreau R, Sherbiny M. Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol 2021;33:1023-8. [PMID: 33905215 DOI: 10.1097/MEG.0000000000002165] [Reference Citation Analysis]
557 Paternostro R, Reiberger T, Mandorfer M, Schwarzer R, Schwabl P, Bota S, Ferlitsch M, Trauner M, Peck-radosavljevic M, Ferlitsch A. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis: Plasma renin concentration and cirrhosis. Journal of Gastroenterology and Hepatology 2017;32:184-90. [DOI: 10.1111/jgh.13439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
558 Fabrizi F, Cerutti R, Alfieri CM, Ridruejo E. An Update on Hepatocellular Carcinoma in Chronic Kidney Disease. Cancers (Basel) 2021;13:3617. [PMID: 34298832 DOI: 10.3390/cancers13143617] [Reference Citation Analysis]
559 Bajaj JS, Kakiyama G, Savidge T, Takei H, Kassam ZA, Fagan A, Gavis EA, Pandak WM, Nittono H, Hylemon PB, Boonma P, Haag A, Heuman DM, Fuchs M, John B, Sikaroodi M, Gillevet PM. Antibiotic‐Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant. Hepatology 2018;68:1549-58. [DOI: 10.1002/hep.30037] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
560 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
561 Kim TY, Kim MY, Sohn JH, Kim SM, Ryu JA, Lim S, Kim Y. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci. 2014;29:1253-1259. [PMID: 25246744 DOI: 10.3346/jkms.2014.29.9.1253] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
562 Sandahl TD, Støy SH, Laursen TL, Rødgaard-Hansen S, Møller HJ, Møller S, Vilstrup H, Grønbæk H. The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients. PLoS One 2017;12:e0189345. [PMID: 29236785 DOI: 10.1371/journal.pone.0189345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
563 Lavayssière L, Kallab S, Cardeau-Desangles I, Nogier MB, Cointault O, Barange K, Muscari F, Rostaing L, Kamar N. Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure. J Gastroenterol Hepatol. 2013;28:1019-1024. [PMID: 23425070 DOI: 10.1111/jgh.12159] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
564 Perkins JD, Halldorson JB, Bakthavatsalam R, Fix OK, Carithers RL Jr, Reyes JD. Should liver transplantation in patients with model for end-stage liver disease scores <or= 14 be avoided? A decision analysis approach. Liver Transpl. 2009;15:242-254. [PMID: 19177441 DOI: 10.1002/lt.21703] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
565 D'Amico M, Izes J, Das A. Case report: Bilateral emphysematous pyelonephritis with pneumatosis intestinalis. Urol Case Rep 2022;40:101895. [PMID: 34712588 DOI: 10.1016/j.eucr.2021.101895] [Reference Citation Analysis]
566 Marrocco-Trischitta MM, Kahlberg A, Astore D, Tshiombo G, Mascia D, Chiesa R. Outcome in cirrhotic patients after elective surgical repair of infrarenal aortic aneurysm. J Vasc Surg. 2011;53:906-911. [PMID: 21215574 DOI: 10.1016/j.jvs.2010.10.095] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
567 Bucsics T, Schoder M, Goeschl N, Schwabl P, Mandorfer M, Diermayr M, Feldner M, Riedl F, Bauer D, Angermayr B, Cejna M, Ferlitsch A, Sieghart W, Trauner M, Peck-radosavljevic M, Karner J, Karnel F, Reiberger T. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Digestive and Liver Disease 2017;49:1360-7. [DOI: 10.1016/j.dld.2017.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
568 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
569 Beghè B, Clini E. Prognostication by concomitant organ failure in mechanically ventilated patients in ICU: Important issue to face with. Eur J Intern Med 2019;70:10-2. [PMID: 31704165 DOI: 10.1016/j.ejim.2019.09.007] [Reference Citation Analysis]
570 Cardoso CC, Matiollo C, Pereira CHJ, Fonseca JS, Alves HEL, Silva OMD, Menegassi VS, Schiavon LL, Santos-Silva MC. B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis. Clin Res Hepatol Gastroenterol 2021;45:101698. [PMID: 33852953 DOI: 10.1016/j.clinre.2021.101698] [Reference Citation Analysis]
571 Heimbach JK. Liver transplantation for hepatocellular carcinoma. Cancer J 2008;14:95-9. [PMID: 18391614 DOI: 10.1097/PPO.0b013e31816a0f6f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
572 Chae MS, Moon KU, Chung HS, Park CS, Lee J, Choi JH, Hong SH. Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor liver transplantation. PLoS One 2018;13:e0195262. [PMID: 29649247 DOI: 10.1371/journal.pone.0195262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
573 Qi X, Dai J, Yang M, Ren W, Jia J, Guo X. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Gastroenterol Res Pract. 2015;2015:480842. [PMID: 25810714 DOI: 10.1155/2015/480842] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
574 Lunova M, Frankova S, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Sticova E, Spicak J, Jirsa M, Sperl J. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis. Physiol Res 2021;70:563-77. [PMID: 34062072 DOI: 10.33549/physiolres.934626] [Reference Citation Analysis]
575 Li Q, Wu Y, Zhu Q, Meng F, Lin S, Liu B, Li B, Tang S, Yang Y, Li Y, Yuan S, Chen Y, Qi X. External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. Ann Transl Med 2019;7:755. [PMID: 32042771 DOI: 10.21037/atm.2019.11.78] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
576 Peguero A, Parra RA, Carrillo SP, Rojas-Suarez J, Figueras F. Association of plasma lactate concentration at admission of severe preeclampsia to maternal complications. Pregnancy Hypertens 2019;17:89-93. [PMID: 31487663 DOI: 10.1016/j.preghy.2019.05.003] [Reference Citation Analysis]
577 Amoyal N, Fernandez AC, Ng R, Fehon DC. Measuring Coping Behavior in Liver Transplant Candidates: A Psychometric Analysis of the Brief COPE. Prog Transplant 2016;26:277-85. [PMID: 27358343 DOI: 10.1177/1526924816655253] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
578 Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-fischer P, Sawhney R, Mookerjee R, Caraceni P, Moreau R, Ginès P, Durand F, Angeli P, Alessandria C, Laleman W, Trebicka J, Samuel D, Zeuzem S, Gustot T, Gerbes AL, Wendon J, Bernardi M, Arroyo V. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. Journal of Hepatology 2015;62:831-40. [DOI: 10.1016/j.jhep.2014.11.012] [Cited by in Crossref: 164] [Cited by in F6Publishing: 140] [Article Influence: 23.4] [Reference Citation Analysis]
579 Benko T, Gallinat A, Minor T, Saner FH, Sotiropoulos GC, Paul A, Hoyer DP. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers: . European Journal of Gastroenterology & Hepatology 2017;29:716-22. [DOI: 10.1097/meg.0000000000000851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
580 Gelu-Simeon M, Bayan T, Ostos M, Boufassa F, Teicher E, Steyaert JM, Bertucci I, Anty R, Pageaux GP, Meyer L, Duclos-Vallée JC; ANRS HC EP 25 PRETHEVIC study group. MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study). Medicine (Baltimore) 2015;94:e1239. [PMID: 26222860 DOI: 10.1097/MD.0000000000001239] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
581 Fonseca-neto OCLD, Miranda LEC, Melo PSVD, Sabat BD, Amorim AG, Lacerda CM. Preditores de injúria renal aguda em pacientes submetidos ao transplante ortotópico de fígado convencional sem desvio venovenoso. ABCD, arq bras cir dig 2011;24:152-8. [DOI: 10.1590/s0102-67202011000200012] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
582 Moon HW, Park M, Hur M, Kim H, Choe WH, Yun YM. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases. Ann Lab Med 2018;38:331-7. [PMID: 29611383 DOI: 10.3343/alm.2018.38.4.331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
583 Baccour L. Amended fused TOPSIS-VIKOR for classification (ATOVIC) applied to some UCI data sets. Expert Systems with Applications 2018;99:115-25. [DOI: 10.1016/j.eswa.2018.01.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 7.8] [Reference Citation Analysis]
584 Arain SQ, Talpur FN, Channa NA, Ali MS, Afridi HI. Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients. Lipids Health Dis. 2017;16:51. [PMID: 28249586 DOI: 10.1186/s12944-017-0437-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
585 Rogalski P, Rogalska-Plonska M, Wroblewski E, Kostecka-Roslen I, Dabrowska M, Swidnicka-Siergiejko A, Wasielica-Berger J, Cydzik M, Hirnle T, Flisiak R, Dabrowski A. Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding. Thromb Res 2019;178:41-6. [PMID: 30959281 DOI: 10.1016/j.thromres.2019.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
586 Shin SW, Kim TY, Jeong WK, Kim Y, Kim J, Kim YH, Park HC, Sohn JH. Usefulness of B-mode and doppler sonography for the diagnosis of severe acute viral hepatitis A. J Clin Ultrasound 2015;43:384-92. [PMID: 25195942 DOI: 10.1002/jcu.22234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
587 Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging. 2009;29:1317-1322. [PMID: 19472388 DOI: 10.1002/jmri.21795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
588 Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, Longrenn T, Mussen F, Peacock S, Watkins J, Ijzerman M. Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 2016;19:1-13. [PMID: 26797229 DOI: 10.1016/j.jval.2015.12.003] [Cited by in Crossref: 278] [Cited by in F6Publishing: 216] [Article Influence: 46.3] [Reference Citation Analysis]
589 Taefi A, Huang CC, Kolli K, Ebrahimi S, Patel M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int. 2015;9:454-460. [PMID: 26088296 DOI: 10.1007/s12072-015-9638-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
590 Kim TY, Kim MY, Sohn JH, Kim SM, Ryu JA, Lim S, Kim Y. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci. 2014;29:1253-1259. [PMID: 25246744 DOI: 10.3346/jkms.20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
591 Shah NL, Intagliata NM, Henry ZH, Argo CK, Northup PG. Spontaneous bacterial peritonitis prevalence in pre-transplant patients and its effect on survival and graft loss post-transplant. World J Hepatol 2016; 8(36): 1617-1622 [PMID: 28083084 DOI: 10.4254/wjh.v8.i36.1617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
592 Vitiello GA, Wang A, Lee RM, Russell MC, Yopp A, Ryon EL, Goel N, Luu S, Hsu C, Silberfein E, Correa-Gallego C, Berman RS, Lee AY. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals. J Surg Oncol 2021;123:963-9. [PMID: 33497478 DOI: 10.1002/jso.26381] [Reference Citation Analysis]
593 Xavier S, Norris CM, Ewasiuk A, Kutsogiannis DJ, Bagshaw SM, van Diepen S, Townsend DR, Negendran J, Karvellas CJ. The impact of cirrhosis in patients undergoing cardiac surgery: a retrospective observational cohort study. Can J Anaesth 2020;67:22-31. [PMID: 31571117 DOI: 10.1007/s12630-019-01493-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
594 Kleinegris MC, Bos MH, Roest M, Henskens Y, Ten Cate-Hoek A, Van Deursen C, Spronk HM, Reitsma PH, De Groot PG, Ten Cate H. Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity. J Thromb Haemost. 2014;12:1647-1657. [PMID: 25142532 DOI: 10.1111/jth.12706] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
595 Etogo-Asse FE, Vincent RP, Hughes SA, Auzinger G, Le Roux CW, Wendon J, Bernal W. High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness. Liver Int. 2012;32:128-136. [PMID: 22098564 DOI: 10.1111/j.1478-3231.2011.02657.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
596 . III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático. Cirugía Española 2011;89:487-504. [DOI: 10.1016/j.ciresp.2011.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
597 Yunhua T, Qiang Z, Lipeng J, Shanzhou H, Zebin Z, Fei J, Zhiheng Z, Linhe W, Weiqiang J, Dongping W, Zhiyong G, Xiaoshun H. Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation. Transplant Proc 2018;50:202-10. [PMID: 29407310 DOI: 10.1016/j.transproceed.2017.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
598 Nie Y, Liu LX, Chen T, Zhang Y, Zhu X. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study. Epidemiol Infect 2021;149:e26. [PMID: 33397544 DOI: 10.1017/S0950268820003143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
599 Deng H, Qi X, Zhang Y, Peng Y, Li J, Guo X. Diagnostic accuracy of contrast-enhanced computed tomography for esophageal varices in liver cirrhosis: a retrospective observational study. J Evid Based Med. 2017;10:46-52. [PMID: 27792276 DOI: 10.1111/jebm.12226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
600 Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659-668. [PMID: 21045793 DOI: 10.1038/nrgastro.2010.169] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
601 He FL, Li C, Liu FQ, Qi XS. Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study. World J Clin Cases 2019; 7(2): 130-136 [PMID: 30705890 DOI: 10.12998/wjcc.v7.i2.130] [Reference Citation Analysis]
602 Åberg F, Nordin A, Mäkisalo H, Isoniemi H. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival-benefit estimation. Scand J Gastroenterol 2015;50:1144-51. [PMID: 25865580 DOI: 10.3109/00365521.2015.1028992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
603 Glargaard S, Boysen T, Pilely K, Garred P, Ytting H. Prognostic value of lectin pathway molecules and complement proteins in ascitic fluid and blood in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 2018;53:64-9. [DOI: 10.1080/00365521.2017.1386710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
604 Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, Tung JP, Scott J, Padbury RT, Harley HA, Bardy PG. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis. 2009;48:410-417. [PMID: 19143554 DOI: 10.1086/596313] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
605 Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311 [PMID: 32742572 DOI: 10.4254/wjh.v12.i6.298] [Reference Citation Analysis]
606 Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology 2021;73:571-85. [PMID: 32246544 DOI: 10.1002/hep.31256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
607 Nouri-Vaskeh M, Khalili N, Khalaji A, Behnam P, Alizadeh L, Ebrahimi S, Gilani N, Mohammadi M, Madinehzadeh SA, Zarei M. Circulating glucagon-like peptide-1 level in patients with liver cirrhosis. Arch Physiol Biochem 2020;:1-6. [PMID: 33043692 DOI: 10.1080/13813455.2020.1828479] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
608 Ye Y, Desai R, Vargas Abello LM, Rajeswaran J, Klein AL, Blackstone EH, Pettersson GB. Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease. The Journal of Thoracic and Cardiovascular Surgery 2014;148:2012-2020.e8. [DOI: 10.1016/j.jtcvs.2014.02.082] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
609 Bambha KM, Biggins SW. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions. Curr Opin Organ Transplant. 2008;13:227-233. [PMID: 18685308 DOI: 10.1097/MOT.0b013e3282ff84c7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
610 Gholamipoor D, Nassiri-Toosi M, Azadi M, Asadi Gharabaghi M. The Relationship Between Airway Occlusion Pressure and Severity of liver Cirrhosis in Candidates for Liver Transplantation. Middle East J Dig Dis 2020;12:111-5. [PMID: 32626564 DOI: 10.34172/mejdd.2020.170] [Reference Citation Analysis]
611 Shaukat A, Church TR, Shanley R, Kauff ND, O'Brien MJ, Mills GM, Jordan PA, Allen JA, Kim A, Feld AD. Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2015;24:913-920. [PMID: 25800242 DOI: 10.1158/1055-9965.EPI-14-1321] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
612 Altorjay I, Vitalis Z, Tornai I, Palatka K, Kacska S, Farkas G, Udvardy M, Harsfalvi J, Dinya T, Orosz P. Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. J Hepatol. 2010;53:484-491. [PMID: 20605050 DOI: 10.1016/j.jhep.2010.03.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
613 Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore). 2016;95:e2877. [PMID: 26937922 DOI: 10.1097/md.0000000000002877] [Cited by in Crossref: 168] [Cited by in F6Publishing: 88] [Article Influence: 28.0] [Reference Citation Analysis]
614 Utsumi M, Umeda Y, Yagi T, Nagasaka T, Shinoura S, Yoshida R, Nobuoka D, Kuise T, Fuji T, Takagi K, Takaki A, Fujiwara T. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis? Dig Surg 2018;36:59-66. [DOI: 10.1159/000486548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
615 Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H, Hwang SG, Kim DJ, Lee BS, Lee SH, Kim HS, Jang JY, Lee CH, Kim BS, Jang YO, Cho MY, Jung ES, Kim YM, Bae SH, Baik SK. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. Hepatology. 2016;64:2185-2197. [PMID: 27339398 DOI: 10.1002/hep.28693] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 17.2] [Reference Citation Analysis]
616 Yoo JJ, Yu SJ, Lee B, Cho EJ, Lee JH, Kim SG, Kim YJ, Kim YS, Yoon JH. Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B. Gut Liver 2020;14:377-86. [PMID: 31533399 DOI: 10.5009/gnl19112] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
617 Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Liver Transpl. 2012;18:1456-1463. [PMID: 22965903 DOI: 10.1002/lt.23548] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
618 Hayashi T, Watanabe T, Shibata M, Kumei S, Oe S, Miyagawa K, Honma Y, Harada M. Endoscopic injection sclerotherapy improves liver function compared with endoscopic variceal ligation. Sci Rep 2021;11:20479. [PMID: 34650156 DOI: 10.1038/s41598-021-99855-z] [Reference Citation Analysis]
619 Martín–llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, Solá E, Pereira G, Marinelli M, Pavesi M, Fernández J, Rodés J, Arroyo V, Ginès P. Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis. Gastroenterology 2011;140:488-496.e4. [DOI: 10.1053/j.gastro.2010.07.043] [Cited by in Crossref: 217] [Cited by in F6Publishing: 172] [Article Influence: 19.7] [Reference Citation Analysis]
620 Yim SY, Lee JH, Ahn H, Kim SU, Kim SG, Kim YS, Kim JH, Choe WH, Kim TY, Jung YK, Suh SJ, Suk KT, An H, Yim HJ, Seo YS, Um SH. Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals. J Clin Gastroenterol 2016;50:676-85. [PMID: 27203430 DOI: 10.1097/MCG.0000000000000529] [Reference Citation Analysis]
621 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
622 Sharif KF, Baik FM, Jategaonkar AA, Khorsandi AS, Urken ML. Septic arthritis of the sternoclavicular joint: A unique late complication after tracheostomy. Am J Otolaryngol 2018;39:646-8. [PMID: 29776683 DOI: 10.1016/j.amjoto.2018.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
623 Kuroda H, Abe T, Fujiwara Y, Nagasawa T, Suzuki Y, Kakisaka K, Takikawa Y. Contrast-Enhanced Ultrasonography-Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure. Hepatology 2021;73:2455-67. [PMID: 33151580 DOI: 10.1002/hep.31615] [Reference Citation Analysis]
624 Komoda T, Frumkin A, Knosalla C, Hetzer R. Child-Pugh Score Predicts Survival After Radical Pericardiectomy for Constrictive Pericarditis. The Annals of Thoracic Surgery 2013;96:1679-85. [DOI: 10.1016/j.athoracsur.2013.06.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
625 Kim BH, Park JW, Nam BH, Kwak HW, Kim WR. Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study. Liver Int. 2014;34:e317-e323. [PMID: 24606128 DOI: 10.1111/liv.12519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
626 Zhang W, Ning N, Li X, Li M, Duan X, Guo Y, Dang Y, Li Y, Gao J, Ye J, Yang J. Impaired brain glucose metabolism in cirrhosis without overt hepatic encephalopathy: a retrospective 18F-FDG PET/CT study. Neuroreport 2019;30:776-82. [PMID: 31261240 DOI: 10.1097/WNR.0000000000001284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Sabbà C, Pompili M. Review article: the hepatic manifestations of hereditary haemorrhagic telangiectasia. Alimentary Pharmacology & Therapeutics 2008;28:523-33. [DOI: 10.1111/j.1365-2036.2008.03775.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
628 Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Dig Liver Dis 2009;41:700-6. [PMID: 19502118 DOI: 10.1016/j.dld.2009.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
629 Yap EML, Supe MGS, Yu II. Cardiac Profile of Filipino Patients With Liver Cirrhosis: A 10-Year Study. Cardiol Res 2018;9:358-63. [PMID: 30627286 DOI: 10.14740/cr804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
630 Xavier SA, Vilas-boas R, Boal Carvalho P, Magalhães JT, Marinho CM, Cotter JB. Assessment of prognostic performance of Albumin–Bilirubin, Child–Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding: . European Journal of Gastroenterology & Hepatology 2018;30:652-8. [DOI: 10.1097/meg.0000000000001087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
631 Singh S, Verma N, Singh V. Letter to the Editor: MELD-Lactate-the New Kid on the Block. Hepatology 2020;72:1883. [PMID: 32330335 DOI: 10.1002/hep.31286] [Reference Citation Analysis]
632 Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Alimentary Pharmacology & Therapeutics 2009;30:3-13. [DOI: 10.1111/j.1365-2036.2009.04002.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
633 Oltean M, Barrenäs C, Martins PN, Herlenius G, Gustafsson B, Friman S, Bennet W. Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation. Gastroenterol Res Pract 2016;2016:6964856. [PMID: 27313607 DOI: 10.1155/2016/6964856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
634 Anderson CL, Saad WE, Kalagher SD, Caldwell S, Sabri S, Turba UC, Matsumoto AH, Angle JF. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience. J Vasc Interv Radiol 2010;21:1370-6. [PMID: 20691610 DOI: 10.1016/j.jvir.2010.05.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
635 Sun S, Xu B, Tan W, Xiang X, Zhou Y, Dan Y, Guo Y, Tan Z, Deng G. Testosterone and Estradiol as Novel Prognostic Indicators for HBV-Related Acute-on-Chronic Liver Failure. Front Med (Lausanne) 2021;8:729030. [PMID: 34568387 DOI: 10.3389/fmed.2021.729030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
636 Tang R, Han D, Li M, Shen S, Huang X, Zhao W, Dong J. Left renal vein ligation for large splenorenal shunt during liver transplantation: LRVL for liver transplantation. ANZ J Surg 2017;87:767-72. [DOI: 10.1111/ans.14044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
637 Horii R, Honda M, Shirasaki T, Shimakami T, Shimizu R, Yamanaka S, Murai K, Kawaguchi K, Arai K, Yamashita T, Sakai Y, Yamashita T, Okada H, Nakamura M, Mizukoshi E, Kaneko S. MicroRNA-10a Impairs Liver Metabolism in Hepatitis C Virus-Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator-Like 1. Hepatol Commun 2019;3:1687-703. [PMID: 31832575 DOI: 10.1002/hep4.1431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
638 Xu Y, Li N, Lu M, Dixon E, Myers RP, Jolley RJ, Quan H. Comparison of risk adjustment methods in patients with liver disease using electronic medical record data. BMC Gastroenterol 2017;17:5. [PMID: 28061757 DOI: 10.1186/s12876-016-0559-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
639 Ghinolfi D, Martí J, Rodríguez-Laiz G, Sturdevant M, Iyer K, Bassi D, Scher C, Schwartz M, Schiano T, Sogawa H. The beneficial impact of temporary porto-caval shunt in orthotopic liver transplantation: a single center analysis. Transpl Int. 2011;24:243-250. [PMID: 20875093 DOI: 10.1111/j.1432-2277.2010.01168.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
640 Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C. Elevated Soluble Tumor Necrosis Factor Receptor 75 Concentrations Identify Patients With Liver Cirrhosis at Risk of Death. Clinical Gastroenterology and Hepatology 2008;6:1255-62. [DOI: 10.1016/j.cgh.2008.06.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
641 Potts JR, Howard MR, Verma S. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. European Journal of Gastroenterology & Hepatology 2013;25:659-64. [DOI: 10.1097/meg.0b013e32835d83d9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
642 Helmke S, Colmenero J, Everson GT. Noninvasive assessment of liver function. Curr Opin Gastroenterol. 2015;31:199-208. [PMID: 25714706 DOI: 10.1097/mog.0000000000000167] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
643 Marmo R, Soncini M, Bucci C, Zullo A; GISED study group. The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study. Dig Liver Dis 2021;53:1178-84. [PMID: 33965358 DOI: 10.1016/j.dld.2021.04.004] [Reference Citation Analysis]
644 Mancini A, Campagna F, Amodio P, Tuohy KM. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct. 2018;9:1373-1388. [PMID: 29485654 DOI: 10.1039/c7fo01528c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
645 Fiaccadori E, Regolisti G, Cademartiri C, Cabassi A, Picetti E, Barbagallo M, Gherli T, Castellano G, Morabito S, Maggiore U. Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment. Clin J Am Soc Nephrol 2013;8:1670-8. [PMID: 23990164 DOI: 10.2215/CJN.00510113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
646 Khoshnood A, Nasiri Toosi M, Faravash MJ, Esteghamati A, Froutan H, Ghofrani H, Kalani M, Miroliaee A, Abdollahi A, Yasir A. A survey of correlation between insulin-like growth factor-I (igf-I) levels and severity of liver cirrhosis. Hepat Mon. 2013;13:e6181. [PMID: 23599716 DOI: 10.5812/hepatmon.6181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
647 Gaba RC, Shah KD, Couture PM, Parvinian A, Minocha J, Knuttinen MG, Bui JT. Within-patient temporal variance in MELD score and impact on survival prediction after TIPS creation. Annals of Hepatology 2013;12:797-802. [DOI: 10.1016/s1665-2681(19)31322-5] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
648 Au KP, Chan AC. Is living donor liver transplantation justified in high model for end-stage liver disease candidates (35+)? Current Opinion in Organ Transplantation 2019;24:637-43. [DOI: 10.1097/mot.0000000000000689] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
649 Bessey JT, Le HV, Leonard DA, Bono CM, Harris MB, Kang JD, Schoenfeld AJ. The effect of chronic liver disease on acute outcomes following cervical spine trauma. The Spine Journal 2016;16:1194-9. [DOI: 10.1016/j.spinee.2016.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
650 Ozolina A, Nemme J, Ozolins A, Bjertnæs LJ, Vanags I, Gardovskis J, Viksna L, Krumina A. Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study. Front Med (Lausanne) 2018;5:253. [PMID: 30255021 DOI: 10.3389/fmed.2018.00253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
651 David AI, Coelho MP, Paes AT, Leite AK, Della Guardia B, de Almeida MD, Meira SP, de Rezende MB, Afonso RC, Ferraz-Neto BH. Liver transplant outcome: a comparison between high and low MELD score recipients. Einstein (Sao Paulo). 2012;10:57-61. [PMID: 23045827 DOI: 10.1590/s1679-45082012000100012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
652 Qiang L, Qin J, Sun C, Sheng Y, Chen W, Qiu B, Chen X, Chen Y, Liu F, Wu G. A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:301. [PMID: 32938405 DOI: 10.1186/s12876-020-01437-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
653 Liu C, Wang YM, Fan K. Epidemiological and clinical features of hepatitis B virus related liver failure in China. World J Gastroenterol 2011; 17(25): 3054-3059 [PMID: 21799653 DOI: 10.3748/wjg.v17.i25.3054] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
654 Poynard T, Imbert-bismut F. Laboratory Testing for Liver Disease. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 201-15. [DOI: 10.1016/b978-1-4377-0881-3.00014-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
655 Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology. 2008;135:1582-1590. [PMID: 18647604 DOI: 10.1053/j.gastro.2008.06.043] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
656 Monte da Silva AG, deA Roza Aguiar B, Chiavegato LD. Association Between Dyspnea and Severity of Liver Disease in Patients in the Pre-transplantation Period-A Pilot Study. Transplant Proc 2016;48:2328-32. [PMID: 27742290 DOI: 10.1016/j.transproceed.2016.06.027] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
657 Matei D, Craciun R, Crisan D, Procopet B, Mocan T, Pasca S, Zaharie R, Popovici B, Sparchez Z. Hepatic Hydrothorax-An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis. J Clin Med 2021;10:3688. [PMID: 34441984 DOI: 10.3390/jcm10163688] [Reference Citation Analysis]
658 Yang TW, Wang CC, Tsai MC, Wang YT, Tseng MH, Lin CC. Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study. Int J Environ Res Public Health 2020;17:E2825. [PMID: 32325957 DOI: 10.3390/ijerph17082825] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
659 Benson JC, Payabvash S, Thalken GL, Alonso J, Rykken J, Ott F, McKinney AM. Delineation of microhemorrhage in acute hepatic encephalopathy using susceptibility-weighted imaging. Eur J Radiol 2016;85:629-34. [PMID: 26860677 DOI: 10.1016/j.ejrad.2015.12.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
660 Lum EL, Cárdenas A, Martin P, Bunnapradist S. Current Status of Simultaneous Liver‐Kidney Transplantation in the United States. Liver Transpl 2019;25:797-806. [DOI: 10.1002/lt.25444] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
661 Dao L, Ragoonanan D, Yi S, Swinford R, Petropoulos D, Mahadeo KM, Li S. The Organ Trail: A Review of Biomarkers of Organ Failure. Front Oncol 2020;10:579219. [PMID: 33262945 DOI: 10.3389/fonc.2020.579219] [Reference Citation Analysis]
662 Martins AMA, Garcia JHP, Eberlin MN. Mass Spectrometry as a Clinical Integrative Tool to Evaluate Hepatocellular Carcinoma: Moving to the Mainstream. Expert Rev Gastroenterol Hepatol 2019;13:821-5. [PMID: 31382786 DOI: 10.1080/17474124.2019.1651643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
663 Yazawa M, Maliakkal B, Nair S, Podila PSB, Agbim UA, Karri S, Khan SD, Maluf D, Eason JD, Molnar MZ, Satapathy SK. Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure. Clin Transl Gastroenterol 2020;11:e00185. [PMID: 32568475 DOI: 10.14309/ctg.0000000000000185] [Reference Citation Analysis]
664 Kim HY, Lee JE, Ko JS, Gwak MS, Lee SK, Kim GS. Intraoperative management of liver transplant recipients having severe renal dysfunction: results of 42 cases. Ann Surg Treat Res 2018;95:45-53. [PMID: 29963539 DOI: 10.4174/astr.2018.95.1.45] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
665 Bishay K, Tandon P, Fisher S, Yelle D, Carrigan I, Wooller K, Kelly E. Clinical Factors Associated with Mortality in Cirrhotic Patients Presenting with Upper Gastrointestinal Bleeding. J Can Assoc Gastroenterol 2020;3:127-34. [PMID: 32395687 DOI: 10.1093/jcag/gwy075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
666 Rudzinski W, Waller AH, Prasad A, Sood S, Gerula C, Samanta A, Koneru B, Klapholz M. New index for assessing the chronotropic response in patients with end-stage liver disease who are undergoing dobutamine stress echocardiography. Liver Transpl 2012;18:355-60. [PMID: 22140006 DOI: 10.1002/lt.22476] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
667 Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Florman S, Blumberg E. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010;138:159-164. [PMID: 19800334 DOI: 10.1053/j.gastro.2009.09.053] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
668 Ye J, Huang Y, Sun Y, Shao C, Zhang S, Wang W, Zhong B. Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. Ann Transl Med 2021;9:1613. [PMID: 34926657 DOI: 10.21037/atm-21-3142] [Reference Citation Analysis]
669 Kakisaka K, Kataoka K, Kuroda H, Takikawa Y. Predictive formula for acute liver failure is useful for predicting the prognosis of patients with acute-on-chronic liver failure: A predictive formula for the prognosis of liver failure in ACLF. Hepatol Res 2016;46:459-67. [DOI: 10.1111/hepr.12577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
670 Ayllón MD, Ciria R, Cruz-ramírez M, Pérez-ortiz M, Gómez I, Valente R, O'grady J, de la Mata M, Hervás-martínez C, Heaton ND, Briceño J. Validation of artificial neural networks as a methodology for donor-recipient matching for liver transplantation: Ayllón et al. Liver Transpl 2018;24:192-203. [DOI: 10.1002/lt.24870] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
671 Li S, Zhang X, Li Q, Lv B, Zhang Y, Jia J, Yue X, Lu W. Development and validation of the nomogram based on INR and eGFR for estimation of mortality in patients with acute-on-chronic hepatitis B liver failure. BMC Gastroenterol 2021;21:474. [PMID: 34911462 DOI: 10.1186/s12876-021-02054-3] [Reference Citation Analysis]
672 Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol 2017;67:517-25. [PMID: 28483678 DOI: 10.1016/j.jhep.2017.04.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
673 Montano‐loza AJ, Wasilenko S, Bintner J, Mason AL. Cyclosporine A Protects Against Primary Biliary Cirrhosis Recurrence After Liver Transplantation. American Journal of Transplantation 2010;10:852-8. [DOI: 10.1111/j.1600-6143.2009.03006.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
674 Zhou W, Wang G, Liu Y, Tao Y, Du Z, Tang Y, Qiao F, Liu Y, Xu Z. Outcomes and risk factors of postoperative hepatic dysfunction in patients undergoing acute type A aortic dissection surgery. J Thorac Dis 2019;11:3225-33. [PMID: 31559024 DOI: 10.21037/jtd.2019.08.72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
675 Lladó L, Bustamante J. IV Reunión de Consenso de la Sociedad Española de Trasplante Hepático 2012. Excepciones al Model for End-stage Liver Disease en la priorización para trasplante hepático. Gastroenterología y Hepatología 2014;37:83-91. [DOI: 10.1016/j.gastrohep.2013.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
676 Lichtenstern C, Hochreiter M, Zehnter VD, Brenner T, Hofer S, Mieth M, Büchler MW, Martin E, Weigand MA, Schemmer P, Busch CJ. Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation: IFI in MELD era. Mycoses 2013;56:350-7. [DOI: 10.1111/myc.12041] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
677 Kim TH, Ku DH, Um SH, Lee HA, Park SW, Chang JM, Yim SY, Suh SJ, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Ahn H. How can we improve the performance of Model for End-Stage Liver Disease sodium score in patients with hepatitis B virus-related decompensated liver cirrhosis commencing antiviral treatment?: Revised MELDNa score for HBV-decompensated LC. Journal of Gastroenterology and Hepatology 2018;33:1641-8. [DOI: 10.1111/jgh.14128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
678 Dogan S, Gurakar A. Liver Transplantation Update: 2014. Euroasian J Hepatogastroenterol 2015;5:98-106. [PMID: 29201702 DOI: 10.5005/jp-journals-10018-1144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
679 Radosa CG, Radosa JC, Grosche-Schlee S, Zöphel K, Plodeck V, Kühn JP, Kotzerke J, Hoffmann RT. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice. Cardiovasc Intervent Radiol 2019;42:405-12. [PMID: 30603976 DOI: 10.1007/s00270-018-2133-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
680 Kaiser T, Zeuzem S, Lichtinghagen R, Welker MW, Geilenkeuser WJ, Kruse R, Neumaier M, Thiery J, Schmidt M. Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation. Clin Chem Lab Med 2014;52:e287-9. [PMID: 24960153 DOI: 10.1515/cclm-2014-0088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
681 Mansfield AS, Rudek MA, Vulih D, Smith GL, Harris PJ, Ivy SP; NCI Organ Dysfunction Working Group. The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects. Clin Cancer Res 2016;22:5472-9. [PMID: 27189163 DOI: 10.1158/1078-0432.CCR-16-0449] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
682 Li J, Gong QM, Xie PL, Lin JY, Chen J, Wei D, Yu DM, Han Y, Zhang XX. Prognostic value of anti-HBc quantification in hepatitis B virus related acute-on-chronic liver failure. J Gastroenterol Hepatol 2021;36:1291-9. [PMID: 33091955 DOI: 10.1111/jgh.15310] [Reference Citation Analysis]
683 Guo Y, He Y, Zhang Y, Zhou Y, Qin Y, Fan C, Ji G, Zhang P, Jia Z. Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-Chronic Hepatitis B Liver Failure: A Case-Control Study. Medicine (Baltimore) 2015;94:e1501. [PMID: 26426612 DOI: 10.1097/MD.0000000000001501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
684 Jaruvongvanich V, Sempokuya T, Wong L. Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma? J Gastrointest Oncol 2018;9:750-61. [PMID: 30151272 DOI: 10.21037/jgo.2018.05.11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
685 Devarbhavi H, Murali AR. Safety of Ascitic Paracentesis in Patients with Budd-Chiari Syndrome on Oral Anticoagulation and Elevated International Normalized Ratio. J Clin Exp Hepatol 2015;5:310-3. [PMID: 26900272 DOI: 10.1016/j.jceh.2015.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
686 Ozersari S, Ünal B, Kemal Çabuk A, Eren Hazir K, Çağri Şimşek E, Ekmekci C, Küçükukur M, Betül Paköz Z, Günay S, Sari C. The prognostic value of P-wave dispersion and left atrial functions assessed with three-dimensional echocardiography in patients with cirrhosis. Eur J Gastroenterol Hepatol 2021;33:1441-50. [PMID: 33741802 DOI: 10.1097/MEG.0000000000002129] [Reference Citation Analysis]
687 Zhang Q, Guan Y, Xiang T, Liu S, Chen Q, Zhang Q. COMBINATION OF MOLECULAR ADSORBENT RECIRCULATING SYSTEM AND RADIOIODINE FOR THE TREATMENT OF CONCURRENT HYPERTHYROIDISM AND SEVERE LIVER DYSFUNCTION: A RETROSPECTIVE COHORT STUDY. Endocr Pract 2017;23:141-8. [PMID: 27819764 DOI: 10.4158/EP161417.OR] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Cita